| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 BCKDK DGKA PTDSS2 DYRK4 POLA2 MYLK3 DSTYK UGP2 FER DLG1 AK4 WEE1 POLR2J3 POLR2L SOSTDC1 STK31 CDC42BPB MYLK2 SGK2 TPK1 HIPK3 FRK TNNI3K TK2 POLR2J2 MAPK3 DCLK1 | 3.96e-07 | 938 | 267 | 33 | GO:0016772 |
| GeneOntologyMolecularFunction | all-trans retinoic acid 18-hydroxylase activity | 2.36e-06 | 3 | 267 | 3 | GO:0062183 | |
| GeneOntologyMolecularFunction | kinase activity | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 BCKDK DGKA DYRK4 MYLK3 DSTYK FER DLG1 AK4 WEE1 SOSTDC1 STK31 CDC42BPB MYLK2 SGK2 TPK1 HIPK3 FRK TNNI3K TK2 MAPK3 DCLK1 | 4.48e-06 | 764 | 267 | 27 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 BCKDK DYRK4 MYLK3 DSTYK SOSTDC1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 TNNI3K MAPK3 DCLK1 | 9.79e-06 | 446 | 267 | 19 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 BCKDK DYRK4 MYLK3 DSTYK FER WEE1 SOSTDC1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 2.04e-05 | 600 | 267 | 22 | GO:0004672 |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.82e-05 | 14 | 267 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 BCKDK DYRK4 DSTYK STK31 CDC42BPB SGK2 HIPK3 TNNI3K MAPK3 DCLK1 | 3.31e-05 | 363 | 267 | 16 | GO:0106310 |
| GeneOntologyMolecularFunction | rRNA (cytosine) methyltransferase activity | 4.59e-05 | 6 | 267 | 3 | GO:0016434 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 BCKDK DGKA DYRK4 MYLK3 DSTYK FER WEE1 SOSTDC1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 8.71e-05 | 709 | 267 | 23 | GO:0016773 |
| GeneOntologyMolecularFunction | myosin binding | 1.43e-04 | 85 | 267 | 7 | GO:0017022 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | METTL15P1 DARS1 WARS2 GGT1 CNOT6 SARS1 NSUN4 DDX49 POLR2J3 POLR2L SLU7 PDE12 DTWD2 LACTB2 POLR2J2 METTL15 | 1.68e-04 | 417 | 267 | 16 | GO:0140098 |
| GeneOntologyMolecularFunction | rRNA (cytosine-N4-)-methyltransferase activity | 1.78e-04 | 2 | 267 | 2 | GO:0071424 | |
| GeneOntologyMolecularFunction | vitamin binding | 3.26e-04 | 161 | 267 | 9 | GO:0019842 | |
| GeneOntologyMolecularFunction | RNA polymerase II activity | 3.60e-04 | 11 | 267 | 3 | GO:0001055 | |
| GeneOntologyMolecularFunction | phosphatidylinositol trisphosphate phosphatase activity | 3.60e-04 | 11 | 267 | 3 | GO:0034594 | |
| GeneOntologyMolecularFunction | iron ion binding | 4.07e-04 | 166 | 267 | 9 | GO:0005506 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | METTL15P1 DARS1 POLA2 WARS2 GGT1 CNOT6 SARS1 NAV2 DNASE1L1 NSUN4 DDX49 POLR2J3 POLR2L SLU7 THAP9 PDE12 DTWD2 LACTB2 POLR2J2 METTL15 | 4.51e-04 | 645 | 267 | 20 | GO:0140640 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 6.51e-04 | 30 | 267 | 4 | GO:0052866 | |
| GeneOntologyMolecularFunction | inositol trisphosphate phosphatase activity | 7.72e-04 | 14 | 267 | 3 | GO:0046030 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 9.43e-04 | 33 | 267 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 9.78e-04 | 57 | 267 | 5 | GO:0015459 | |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 1.05e-03 | 4 | 267 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | cGMP binding | 1.16e-03 | 16 | 267 | 3 | GO:0030553 | |
| GeneOntologyCellularComponent | secretory vesicle | ATP6V1C1 PRAMEF5 ATR TRPM7 PSMD11 F8 ITPR1 STXBP1 MAGED2 NFKB1 KCNJ11 DLG1 PYGL DNASE1L1 PRAMEF6 DOCK2 CRISPLD2 ANPEP PRAMEF19 UBR4 FAM220A DNM1L IDH1 PRAMEF18 STK31 CRHBP MYLK2 FRK EGF CD9 CADPS LNPEP CALCRL | 4.67e-05 | 1246 | 264 | 33 | GO:0099503 |
| GeneOntologyCellularComponent | secretory granule | PRAMEF5 PSMD11 F8 ITPR1 STXBP1 MAGED2 NFKB1 KCNJ11 PYGL DNASE1L1 PRAMEF6 DOCK2 CRISPLD2 ANPEP PRAMEF19 UBR4 FAM220A IDH1 PRAMEF18 STK31 CRHBP FRK EGF CD9 CADPS LNPEP CALCRL | 2.18e-04 | 1014 | 264 | 27 | GO:0030141 |
| GeneOntologyCellularComponent | actin-based cell projection | INPPL1 ACTA1 ACTA2 ACTC1 ADGRV1 TIAM2 FAT1 DLG1 MYO1H SLC34A2 PKHD1L1 ARL4C | 2.31e-04 | 278 | 264 | 12 | GO:0098858 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | PRAMEF5 MARCHF6 PSMC4 DARS1 PSMD11 PSME2 POLA2 DDB1 ITPR1 CNOT6 NFKB1 RMC1 C2orf49 PRAMEF6 DOCK1 RNASEH2B NAA15 POLR2J3 PRAMEF19 ENC1 POLR2L PRAMEF18 BABAM2 TAF6L POLR2J2 PIGM | 2.67e-04 | 972 | 264 | 26 | GO:0140535 |
| Domain | Protein_kinase_ATP_BS | NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK FER WEE1 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 2.60e-05 | 379 | 261 | 17 | IPR017441 |
| Domain | Exo_endo_phos | 2.65e-05 | 26 | 261 | 5 | PF03372 | |
| Domain | - | 2.65e-05 | 26 | 261 | 5 | 3.60.10.10 | |
| Domain | Endo/exonuclease/phosphatase | 3.22e-05 | 27 | 261 | 5 | IPR005135 | |
| Domain | HEAT_REPEAT | 5.44e-05 | 70 | 261 | 7 | PS50077 | |
| Domain | Kinase-like_dom | ATR TRPM7 NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK FER WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 8.11e-05 | 542 | 261 | 20 | IPR011009 |
| Domain | PROTEIN_KINASE_ATP | NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK FER WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 8.64e-05 | 459 | 261 | 18 | PS00107 |
| Domain | ARM-type_fold | PDS5B ATR NEK10 TOGARAM1 TSC2 TEX10 ITPR1 ASPM PDS5A DOCK1 DOCK2 UBR4 APOB HEATR1 IPO13 | 9.06e-05 | 339 | 261 | 15 | IPR016024 |
| Domain | PRAME_family | 1.22e-04 | 19 | 261 | 4 | IPR026271 | |
| Domain | ERAP1-like_C_dom | 1.43e-04 | 8 | 261 | 3 | IPR024571 | |
| Domain | ERAP1_C | 1.43e-04 | 8 | 261 | 3 | PF11838 | |
| Domain | ACTINS_1 | 1.43e-04 | 8 | 261 | 3 | PS00406 | |
| Domain | Ser/Thr_kinase_AS | STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 TNNI3K MAPK3 DCLK1 | 1.60e-04 | 357 | 261 | 15 | IPR008271 |
| Domain | S_TKc | NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 MAPK3 DCLK1 | 1.70e-04 | 359 | 261 | 15 | SM00220 |
| Domain | PROTEIN_KINASE_ST | STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 TNNI3K MAPK3 DCLK1 | 1.86e-04 | 362 | 261 | 15 | PS00108 |
| Domain | Prot_kinase_dom | NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK FER WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 1.90e-04 | 489 | 261 | 18 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK FER WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 FRK TNNI3K MAPK3 DCLK1 | 2.10e-04 | 493 | 261 | 18 | PS50011 |
| Domain | Pkinase | NEK10 STK17B RPS6KA1 RPS6KA3 DYRK4 MYLK3 DSTYK WEE1 STK31 CDC42BPB MYLK2 SGK2 HIPK3 MAPK3 DCLK1 | 3.22e-04 | 381 | 261 | 15 | PF00069 |
| Domain | Peptidase_M1 | 5.41e-04 | 12 | 261 | 3 | IPR001930 | |
| Domain | Oest-rel_rcp | 5.78e-04 | 3 | 261 | 2 | IPR027289 | |
| Domain | SLRP_I_decor/aspor/byglycan | 5.78e-04 | 3 | 261 | 2 | IPR016352 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | PDSS1 ACTA1 TSC2 ITGA2 PDE10A GLI2 DLG1 CNGB1 DOCK2 LRPPRC EGF VCAN CDH13 | 8.80e-10 | 171 | 267 | 13 | 20201926 |
| Pubmed | TRPM7 USP11 BCKDK HSPH1 PSMC4 DDB1 ADCY9 ADD1 ITPR1 NEO1 SARS1 DNAJC10 TMTC3 SACS ERAP2 UBTF RAB3GAP2 ASPM DLG1 AK4 CCDC97 NAA15 ANK2 DNAJC16 SYNE1 UBR4 NIPSNAP1 SLU7 HEATR1 CDC42BPB WDR19 ARHGAP1 LRPPRC PDE12 LNPEP MTR | 1.23e-09 | 1487 | 267 | 36 | 33957083 | |
| Pubmed | CYP2C9 TRPM7 ITFG2 INPPL1 ESRRG HSPH1 TSC2 CCDC178 POLA2 NUP205 UBTF RAB3GAP2 UGP2 ASPM ECEL1 RNASEH2B SIN3B EFL1 HTRA2 WEE1 UBR4 POLR2L DNM1L MRPL33 HEATR1 RUFY1 WDR59 TPK1 TAF6L ARHGAP1 PBRM1 BTBD7 PC | 3.37e-09 | 1327 | 267 | 33 | 32694731 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DPY19L3 ATR HSPH1 MARCHF6 P4HA3 TSC2 PTDSS2 EXTL2 ITGA2 PSME2 DDB1 BGN ITPR1 FAT1 DNAJC10 TMTC3 JMJD8 ECEL1 UBIAD1 DNASE1L1 NPC1 ANPEP DNAJC16 CACHD1 ADAM12 RUFY1 LNPEP IPO13 POFUT1 NGLY1 CDH13 | 4.43e-09 | 1201 | 267 | 31 | 35696571 |
| Pubmed | Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. | 6.27e-09 | 10 | 267 | 5 | 21749862 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 ATP6V1C1 USP11 RPS6KA1 INPPL1 RPS6KA3 HSPH1 ACTA1 PSMC4 DARS1 PSMD11 PSME2 POLA2 DDB1 NUP205 SARS1 MAGED2 RAB3GAP2 UGP2 PYGL NMT1 RNASEH2B EFL1 NAA15 UBR4 DNM1L IDH1 SMC2 RUFY1 BABAM2 GSPT1 PDE12 LNPEP MTR | 8.97e-09 | 1455 | 267 | 34 | 22863883 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 USP11 RPS6KA1 RPS6KA3 PSMC4 PSMD11 DDB1 NUP205 DNAJC10 TMTC3 DLG1 PYGL PLD2 NAA15 DNAJC16 UBR4 MTMR8 DNM1L HEATR1 SMC2 PPEF1 ARHGAP1 PTPDC1 LRPPRC LNPEP NGLY1 MAPK3 | 1.09e-08 | 974 | 267 | 27 | 28675297 |
| Pubmed | PDXDC1 INCENP TRPM7 ADCY9 ADD1 FAT1 NEO1 MAGED2 SYDE2 DLG1 PDS5A DNAJC16 ABCC5 DNM1L APOB FAM171B RUFY1 PKHD1L1 CDC42BPB ARHGAP1 ARL4C DTWD2 PC | 4.38e-08 | 777 | 267 | 23 | 35844135 | |
| Pubmed | 4.86e-08 | 14 | 267 | 5 | 17411366 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 PDS5B HSPH1 PSMC4 TSC2 PTDSS2 PSMD11 TEX10 NUP205 SARS1 TMTC3 MAGED2 RAB3GAP2 PDS5A UBIAD1 NPC1 NAA15 DNAJC16 UBR4 CACHD1 HEATR1 LRPPRC PDE12 MTR POFUT1 | 9.04e-08 | 942 | 267 | 25 | 31073040 |
| Pubmed | PRAMEF5 RPS6KA3 HSPH1 DGKA TIAM2 ITPR1 UBTF DLG1 NMT1 TMEM181 PRAMEF6 NPC1 DDX49 PRAMEF19 ENC1 SLU7 CLDND1 DNM1L APOB HEATR1 FAM171B PRAMEF18 RESF1 VCAN TET1 ACCSL DCLK1 | 9.66e-08 | 1084 | 267 | 27 | 11544199 | |
| Pubmed | PDXDC1 HSPH1 PSMC4 DARS1 PSMD11 DDB1 ADD1 NUP205 SARS1 DNAJC10 MAGED2 PDS5A NAA15 DNAJC16 UBR4 DNM1L HEATR1 SMC2 GSPT1 LRPPRC | 1.38e-07 | 638 | 267 | 20 | 33239621 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 INCENP TRPM7 PDSS1 USP11 BCKDK PSMC4 TSC2 PSMD11 DDB1 WARS2 ADCY9 ITPR1 SARS1 MAGED2 RAB3GAP2 AK4 NAA15 HTRA2 SYNE1 UBR4 NIPSNAP1 DNM1L MRPL33 HEATR1 TRAK1 ARHGAP1 LRPPRC PDE12 TMLHE MTR METTL15 | 1.90e-07 | 1496 | 267 | 32 | 32877691 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B ATR INCENP HSPH1 PSMC4 DARS1 PSMD11 DDB1 NUP205 SARS1 MAGED2 UBTF RAB3GAP2 PDS5A TLN2 NPAS2 HTRA2 SYNE1 UBR4 NIPSNAP1 DNM1L APOB HEATR1 SMC2 GSPT1 LRPPRC PDE12 PBRM1 MTR PC MYBPC1 | 2.08e-07 | 1425 | 267 | 31 | 30948266 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | ATR INPP5D RPS6KA3 DARS1 ADD1 DDX49 SLU7 DNM1L HEATR1 BABAM2 KIF20B GSPT1 KRIT1 TAF6L PC | 2.17e-07 | 370 | 267 | 15 | 22922362 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DARS1 PTDSS2 PSMD11 POLA2 ITPR1 CNOT6 GLI2 NFKB1 DLG1 TLN2 UBIAD1 DOCK1 POLR2J3 TRAK1 HIPK3 CD9 TET1 ACCSL | 2.19e-07 | 536 | 267 | 18 | 15840001 |
| Pubmed | DARS1 PTDSS2 PSMD11 POLA2 ITPR1 CNOT6 GLI2 NFKB1 DLG1 TLN2 UBIAD1 DOCK1 POLR2J3 TRAK1 HIPK3 CD9 TET1 ACCSL | 2.31e-07 | 538 | 267 | 18 | 10512203 | |
| Pubmed | 2.32e-07 | 8 | 267 | 4 | 20096780 | ||
| Pubmed | PDS5B HSPH1 ACTA1 ACTA2 ACTC1 DGKA PDE10A TEX10 NUP205 STXBP1 DNAJC10 MAGED2 SACS UGP2 ASPM NAV2 DLG1 ANK2 SYNE1 UBR4 ABCC5 APOB HEATR1 SMC2 STK31 GSPT1 MYLK2 LRPPRC POFUT1 NGLY1 MYBPC1 | 2.69e-07 | 1442 | 267 | 31 | 35575683 | |
| Pubmed | 3.13e-07 | 58 | 267 | 7 | 31598710 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | HSPH1 DGKA TSC2 SLFN5 DNAH14 NUP205 SARS1 SYDE2 ZFR2 PDS5A GP1BA CACNA1F SIN3B CYP26B1 UBR4 IGDCC3 TAF6L PDE12 CFAP44 HBZ PIGM | 3.15e-07 | 736 | 267 | 21 | 29676528 |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 4.47e-07 | 3 | 267 | 3 | 7780165 | |
| Pubmed | 4.73e-07 | 21 | 267 | 5 | 20230754 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ACTA1 ACTA2 ACTC1 PSME2 GGT1 BGN NPHS2 SARS1 UGP2 PYGL GP1BA CRISPLD2 COL6A3 UBE2NL ANPEP APOB IDH1 ARHGAP1 FRK PTPA EGF CD9 CAPN7 HBZ CDH13 | 9.49e-07 | 1070 | 267 | 25 | 23533145 |
| Pubmed | PDXDC1 INCENP HSPH1 PSMC4 PSMD11 PSME2 POLA2 CNOT6 FAT1 DNAJC10 TMTC3 KCTD15 PDS5A ECEL1 NPC1 NSUN4 UBR4 NIPSNAP1 DNM1L APOB BABAM2 CDC42BPB ARHGAP1 LRPPRC PTPA LNPEP SORBS3 POFUT1 | 9.77e-07 | 1297 | 267 | 28 | 33545068 | |
| Pubmed | ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk. | 1.07e-06 | 11 | 267 | 4 | 16054021 | |
| Pubmed | TOGARAM1 ADGRV1 ADCY9 RAB3GAP2 NAV2 TLN2 DNAJC16 SYNE1 CDC42BPB CADPS POFUT1 | 1.53e-06 | 225 | 267 | 11 | 12168954 | |
| Pubmed | SEMA6D regulates perinatal cardiomyocyte proliferation and maturation in mice. | 1.60e-06 | 12 | 267 | 4 | 31042497 | |
| Pubmed | USP11 PSMC4 DDB1 NUP205 SARS1 MAGED2 RAB3GAP2 RMC1 DOCK1 NSUN4 NAA15 HTRA2 NIPSNAP1 GSPT1 LRPPRC | 1.74e-06 | 437 | 267 | 15 | 20562859 | |
| Pubmed | 1.78e-06 | 4 | 267 | 3 | 8660964 | ||
| Pubmed | 1.78e-06 | 4 | 267 | 3 | 22912494 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B INCENP USP11 HSPH1 PSMC4 DARS1 PSMD11 TEX10 DDB1 NUP205 MAGED2 UBTF ASPM PYGL PDS5A NAA15 DDX49 RASA3 UBR4 NIPSNAP1 SLU7 HEATR1 SMC2 WDR59 KIF20B GSPT1 LRPPRC PDE12 | 2.21e-06 | 1353 | 267 | 28 | 29467282 |
| Pubmed | RELN TRPM7 USP11 HSPH1 DARS1 TSC2 STXBP1 SACS DLG1 TLN2 NPC1 USP13 ANK2 NRCAM SYNE1 UBR4 ENC1 ABCC5 CACHD1 CDC42BPB WDR59 KRIT1 WDR19 ARHGAP1 CADPS PC DCLK1 | 2.56e-06 | 1285 | 267 | 27 | 35914814 | |
| Pubmed | 3.20e-06 | 14 | 267 | 4 | 9687510 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 3.98e-06 | 84 | 267 | 7 | 15203218 | |
| Pubmed | ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease. | 4.11e-06 | 202 | 267 | 10 | 33601422 | |
| Pubmed | 4.42e-06 | 5 | 267 | 3 | 9915826 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | INPPL1 TSC2 ADCY9 TIAM2 FAT1 KCNJ11 NAV2 KCTD15 TLN2 DENND5A NPC1 ARSJ RASA3 UBR4 MTMR8 BABAM2 CDC42BPB WDR59 TRAK1 BTBD7 SORBS3 POFUT1 PC CYTH4 | 5.47e-06 | 1105 | 267 | 24 | 35748872 |
| Pubmed | Structure-function relationship of Vpr: biological implications. | 5.75e-06 | 16 | 267 | 4 | 19275588 | |
| Pubmed | 6.20e-06 | 59 | 267 | 6 | 11279525 | ||
| Pubmed | 6.91e-06 | 35 | 267 | 5 | 19389355 | ||
| Pubmed | BCKDK ACTA1 PSMC4 PSMD11 TEX10 ADCY9 ITPR1 UBTF NFKB1 DLG1 EFL1 MTMR8 CACHD1 FAM171B PPEF1 CDC42BPB ARHGAP1 PTPDC1 PTPA LNPEP SORBS3 MAPK3 PC | 7.43e-06 | 1049 | 267 | 23 | 27880917 | |
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 7.47e-06 | 17 | 267 | 4 | 23565261 | |
| Pubmed | 7.47e-06 | 17 | 267 | 4 | 37781892 | ||
| Pubmed | 7.47e-06 | 17 | 267 | 4 | 8997639 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TEX10 MAGED2 SACS RAB3GAP2 PYGL TLN2 UBR4 HEATR1 SMC2 CDC42BPB ARHGAP1 PDE12 PBRM1 CADPS VCAN | 8.43e-06 | 498 | 267 | 15 | 36634849 |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 12832467 | ||
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 8.80e-06 | 6 | 267 | 3 | 22989508 | |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 12009869 | ||
| Pubmed | Altered vitamin A homeostasis and increased size and adiposity in the rdh1-null mouse. | 8.80e-06 | 6 | 267 | 3 | 17435174 | |
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 8.80e-06 | 6 | 267 | 3 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 8.80e-06 | 6 | 267 | 3 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 8.80e-06 | 6 | 267 | 3 | 21917091 | |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 19020743 | ||
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 8.80e-06 | 6 | 267 | 3 | 8661406 | |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 23017337 | ||
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 9841925 | ||
| Pubmed | Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases. | 8.80e-06 | 6 | 267 | 3 | 8939914 | |
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 8.80e-06 | 6 | 267 | 3 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 8.80e-06 | 6 | 267 | 3 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 8.80e-06 | 6 | 267 | 3 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 8.80e-06 | 6 | 267 | 3 | 11709093 | |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 8.80e-06 | 6 | 267 | 3 | 23875777 | |
| Pubmed | 8.80e-06 | 6 | 267 | 3 | 16626623 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DPY19L3 ATR HSPH1 PSMC4 PEX10 PTDSS2 PSMD11 EXTL2 ADCY9 GGT1 NUP205 FAT1 NEO1 DLG1 PDS5A AK4 UBIAD1 APOB IDH1 PTPA DTWD2 IPO13 PC | 8.91e-06 | 1061 | 267 | 23 | 33845483 |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 9.55e-06 | 18 | 267 | 4 | 39181896 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 9.55e-06 | 18 | 267 | 4 | 29731491 | |
| Pubmed | 9.55e-06 | 18 | 267 | 4 | 14675769 | ||
| Pubmed | 9.55e-06 | 18 | 267 | 4 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 9.55e-06 | 18 | 267 | 4 | 12890732 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | PDXDC1 TRPM7 ITGA2 ADCY9 FAT1 NEO1 NAV2 DLG1 UBIAD1 ANK2 DNAJC16 ABCC5 APOB CDC42BPB KLHL38 LNPEP | 9.93e-06 | 569 | 267 | 16 | 30639242 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | USP11 HSPH1 ACTA2 ACTC1 PSMC4 DARS1 PSMD11 DDB1 ADD1 SARS1 MAGED2 RAB3GAP2 UGP2 PYGL PDS5A NMT1 NAA15 UBR4 NIPSNAP1 DNM1L IDH1 SMC2 GSPT1 LRPPRC | 1.04e-05 | 1149 | 267 | 24 | 35446349 |
| Pubmed | HSPH1 PSMC4 DARS1 DDB1 ADCY9 ADD1 MAGED2 RAB3GAP2 DLG1 PDS5A DOCK1 ANK2 ABCC5 DNM1L CACHD1 SMC2 ARHGAP1 LRPPRC | 1.09e-05 | 708 | 267 | 18 | 39231216 | |
| Pubmed | PDXDC1 PDS5B PSMC4 DARS1 PSMD11 PSME2 DDB1 ADD1 NUP205 SARS1 NMT1 NAA15 UBR4 NIPSNAP1 HEATR1 IDH1 LRPPRC PDE12 | 1.15e-05 | 711 | 267 | 18 | 33022573 | |
| Pubmed | 1.20e-05 | 19 | 267 | 4 | 30700554 | ||
| Pubmed | Deciphering gene expression program of MAP3K1 in mouse eyelid morphogenesis. | 1.20e-05 | 19 | 267 | 4 | 23201579 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.20e-05 | 19 | 267 | 4 | 28604677 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TRPM7 INPPL1 TSC2 DYRK4 MYLK3 SYDE2 DSTYK RAB3GAP2 NAV2 NAA15 WEE1 DNM1L WDR59 MYLK2 TRAK1 LRPPRC RESF1 TET1 PC DCLK1 | 1.31e-05 | 861 | 267 | 20 | 36931259 |
| Pubmed | PDS5B ATR INCENP USP11 PSME2 TEX10 POLA2 DDB1 NUP205 UBTF PYGL PDS5A EFL1 USP13 UBR4 POLR2L DNM1L SMC2 BABAM2 TAF6L PTPA PBRM1 | 1.39e-05 | 1014 | 267 | 22 | 32416067 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V1C1 PSME2 ADGRV1 DDB1 TIAM2 BGN NPHS2 FAT1 STXBP1 UGP2 NPC1 COL6A3 ANPEP IDH1 SMC2 CDC42BPB ARHGAP1 FRK ZNHIT6 EGF CD9 CAPN7 | 1.43e-05 | 1016 | 267 | 22 | 19056867 |
| Pubmed | 1.49e-05 | 20 | 267 | 4 | 26694250 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.49e-05 | 20 | 267 | 4 | 21425410 | |
| Pubmed | 1.49e-05 | 20 | 267 | 4 | 16580637 | ||
| Pubmed | 1.53e-05 | 7 | 267 | 3 | 22535526 | ||
| Pubmed | Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. | 1.53e-05 | 7 | 267 | 3 | 15572151 | |
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 1.53e-05 | 7 | 267 | 3 | 17504171 | |
| Pubmed | 1.53e-05 | 7 | 267 | 3 | 15342917 | ||
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 1.53e-05 | 7 | 267 | 3 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 1.53e-05 | 7 | 267 | 3 | 22640593 | |
| Pubmed | 1.53e-05 | 7 | 267 | 3 | 22465675 | ||
| Pubmed | Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. | 1.53e-05 | 7 | 267 | 3 | 9384381 | |
| Pubmed | 1.53e-05 | 7 | 267 | 3 | 30289203 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | USP11 HSPH1 ACTA2 DDB1 NUP205 MAGED2 PYGL SMC2 RUFY1 MYLK2 LRPPRC PC | 1.63e-05 | 344 | 267 | 12 | 36282215 |
| Pubmed | Myocardial Mycn is essential for mouse ventricular wall morphogenesis. | 1.83e-05 | 21 | 267 | 4 | 23063798 | |
| Pubmed | TSC2 TEX10 DDB1 ADD1 MAGED2 KCNAB1 DLG1 TLN2 SIN3B LRCH2 ANK2 NRCAM SYNE1 UBR4 DNM1L SMC2 CDC42BPB LRPPRC PBRM1 MAPK3 DCLK1 | 2.03e-05 | 963 | 267 | 21 | 28671696 | |
| Pubmed | PDXDC1 USP11 TSC2 PSMD11 SARS1 DNAJC10 PDS5A ECEL1 DNAJC16 HEATR1 WDR59 LRPPRC DTWD2 TMLHE MTR PC | 2.14e-05 | 606 | 267 | 16 | 36538041 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDXDC1 PDS5B ITFG2 USP11 BCKDK PSMC4 TSC2 PSMD11 NUP205 SARS1 DSTYK RAB3GAP2 UGP2 ASPM PDS5A BPIFB3 WEE1 UBR4 NIPSNAP1 HEATR1 SMC2 BABAM2 CDC42BPB LRPPRC MTR | 2.20e-05 | 1284 | 267 | 25 | 17353931 |
| Pubmed | 2.23e-05 | 22 | 267 | 4 | 31729367 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATP6V1C1 HSPH1 PSMC4 DARS1 PSMD11 PSME2 DDB1 NUP205 MAGED2 NFKB1 UGP2 DLG1 PYGL NMT1 NPC1 SIN3B NAA15 UBR4 IDH1 SMC2 GSPT1 ARHGAP1 LRPPRC PDE12 NGLY1 PC | 2.24e-05 | 1367 | 267 | 26 | 32687490 |
| GeneFamily | Actins | 1.78e-05 | 6 | 176 | 3 | 929 | |
| GeneFamily | PRAME family | 7.92e-05 | 24 | 176 | 4 | 686 | |
| GeneFamily | Phosphoinositide phosphatases | 2.52e-04 | 32 | 176 | 4 | 1079 | |
| GeneFamily | Cytochrome P450 family 26 | 2.81e-04 | 3 | 176 | 2 | 1013 | |
| GeneFamily | Aminopeptidases|CD molecules | 5.58e-04 | 17 | 176 | 3 | 104 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP | DDB1 ADCY9 ADD1 NFKB1 NAV2 DNASE1L1 DOCK2 RASA3 SLU7 CD9 CAPN7 CALCRL | 1.01e-06 | 200 | 265 | 12 | M9083 |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | DPY19L3 EREG TOGARAM1 DDB1 BGN ABCD2 C2orf49 CACHD1 DTWD2 CALCRL | 2.65e-06 | 147 | 265 | 10 | M6085 |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 3.79e-06 | 64 | 265 | 7 | M2572 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 6.31e-06 | 69 | 265 | 7 | M10165 | |
| Coexpression | HALLMARK_MYOGENESIS | ACTA1 ACTC1 TSC2 ADCY9 NAV2 COL6A3 ADAM12 CRAT SORBS3 PC CDH13 | 6.61e-06 | 200 | 265 | 11 | M5909 |
| Coexpression | SILIGAN_BOUND_BY_EWS_FLT1_FUSION | 6.73e-06 | 46 | 265 | 6 | M5218 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | PDS5B ATR ESRRG HSPH1 ITPR1 SACS ASPM FER NAA15 SLU7 DNM1L SMC2 KIF20B KRIT1 PBRM1 RESF1 LACTB2 BTBD7 MTR ZNF654 | 1.33e-05 | 656 | 265 | 20 | M18979 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DPY19L3 HSPH1 ACTC1 DARS1 TEX10 DDB1 ADCY9 INPP4B ITPR1 NUP205 VSTM4 FAT1 SARS1 DNAJC10 MAGED2 SACS NAV2 ANK2 RASA3 WEE1 ENC1 ARL4C CD9 CALCRL DCLK1 CDH13 | 1.33e-05 | 1009 | 265 | 26 | M157 |
| Coexpression | GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP | PDXDC1 ITFG2 USP11 MAGEF1 NPC1 NRCAM HTRA2 DNAJC16 WDR59 WDR19 | 1.38e-05 | 177 | 265 | 10 | M5641 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | PDXDC1 PRAMEF5 ZFR2 NFKB1 PLD2 RMC1 PRAMEF6 PRAMEF19 PRAMEF18 EGF | 1.59e-05 | 180 | 265 | 10 | MM612 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PDS5B ATR STK17B INPP5D RPS6KA3 MARCHF6 DGKA DARS1 SLFN5 PSME2 INPP4B ADD1 ITPR1 SACS ERAP2 UBTF DSTYK RAB3GAP2 UGP2 PDS5A DOCK2 SYNE1 UBR4 ID2 CLDND1 IFNAR2 ARL4C RESF1 LNPEP PHF11 MTR NGLY1 CYTH4 | 2.09e-05 | 1492 | 265 | 33 | M40023 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | RPS6KA3 HSPH1 MARCHF6 DGKA DARS1 IFT46 EXTL2 SLFN5 DDB1 ADD1 GGT1 NFKB1 PYGL RMC1 DNASE1L1 NPC1 NSUN4 NAA15 RASA3 WEE1 ID2 SLU7 MRPL33 IDH1 BABAM2 ARHGAP1 ARL4C PDE12 NGLY1 | 2.49e-05 | 1239 | 265 | 29 | M1743 |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | TIAM2 DSTYK TLN2 RNASEH2B ADAM12 RIT2 SGK2 CAPN7 CNGB3 DCLK1 | 3.31e-05 | 196 | 265 | 10 | M4514 |
| Coexpression | GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN | 3.77e-05 | 199 | 265 | 10 | M4390 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | HSPH1 INPP4B ADD1 ECEL1 ATG16L2 SMIM11 ENC1 SOSTDC1 MRPL33 CYTH4 | 3.93e-05 | 200 | 265 | 10 | M306 |
| Coexpression | GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP | 3.93e-05 | 200 | 265 | 10 | M5476 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | RPS6KA3 HSPH1 MARCHF6 DGKA DARS1 IFT46 EXTL2 SLFN5 DDB1 ADD1 GGT1 NFKB1 PYGL RMC1 DNASE1L1 NPC1 NSUN4 NAA15 RASA3 WEE1 ID2 SLU7 MRPL33 IDH1 BABAM2 ARHGAP1 ARL4C PDE12 NGLY1 | 4.29e-05 | 1277 | 265 | 29 | MM1032 |
| Coexpression | PHONG_TNF_RESPONSE_NOT_VIA_P38 | ITGA2 PDE10A INPP4B DNAJC10 NFKB1 NAV2 DENND5A ARSJ HTRA2 ID2 IFNAR2 VCAN PHF11 | 4.90e-05 | 341 | 265 | 13 | M2504 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | PDXDC1 RPS6KA3 ESRRG MARCHF6 PSMD11 GGT1 FAT1 AK4 ANK2 ANPEP WEE1 DNM1L IDH1 KRIT1 LRPPRC CD9 PC | 5.38e-05 | 553 | 265 | 17 | M1475 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | RPS6KA1 MARCHF6 DARS1 TSC2 ITPR1 MAGED2 SACS NFKB1 UGP2 AK4 CLDND1 MRPL33 APOB | 1.17e-04 | 372 | 265 | 13 | M19261 |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.22e-04 | 48 | 265 | 5 | M1568 | |
| Coexpression | APRELIKOVA_BRCA1_TARGETS | 1.35e-04 | 49 | 265 | 5 | MM1178 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL | ESRRG INPP4B GGT1 GHR MAGED2 NAV2 AK4 ABCC5 CLDND1 IDH1 CRAT EGF | 1.44e-04 | 329 | 265 | 12 | M2631 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | F8 ITPR1 NEO1 NAV2 DLG1 AK4 NPC1 USP13 ANK2 ANPEP DNAJC16 SYNE1 FAM171B RUFY1 CRAT PKHD1L1 LACTB2 | 1.56e-04 | 604 | 265 | 17 | M45760 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | ATP6V1C1 HSPH1 PSME2 PDE10A ADCY9 INPP4B DNAJC10 SACS PDS5A AK4 DENND5A NPAS2 ANK2 CDC42BPB GSPT1 ARHGAP1 PTPA LACTB2 PHF11 MTR | 1.72e-04 | 790 | 265 | 20 | M12490 |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_UP | ATR VSTM4 SACS DSTYK RNASEH2B CDC42BPB IPO13 CATSPERB ZNF654 | 1.75e-04 | 195 | 265 | 9 | M7694 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B ATR RPS6KA3 MARCHF6 TOGARAM1 ADCY9 ITPR1 FAT1 SACS NFKB1 DLG1 PDS5A DENND5A DOCK1 USP13 ENC1 KIF20B KRIT1 TRAK1 LRPPRC MTR | 1.82e-04 | 856 | 265 | 21 | M4500 |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP | 1.89e-04 | 197 | 265 | 9 | M8022 | |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN | 1.96e-04 | 198 | 265 | 9 | M8173 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_DC_DN | 1.96e-04 | 198 | 265 | 9 | M5148 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP | 1.96e-04 | 198 | 265 | 9 | M5215 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN | 2.04e-04 | 199 | 265 | 9 | M8109 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN | 2.12e-04 | 200 | 265 | 9 | M5975 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP | 2.12e-04 | 200 | 265 | 9 | M5979 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 2.12e-04 | 200 | 265 | 9 | M3580 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 2.12e-04 | 200 | 265 | 9 | M7168 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 2.12e-04 | 200 | 265 | 9 | M7905 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 2.12e-04 | 200 | 265 | 9 | M5915 | |
| Coexpression | GSE39864_WT_VS_GATA3_KO_TREG_DN | 2.12e-04 | 200 | 265 | 9 | M9063 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.12e-04 | 200 | 265 | 9 | M9136 | |
| Coexpression | ZHU_CMV_24_HR_DN | 2.12e-04 | 84 | 265 | 6 | M4065 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | INPPL1 ADCY9 INPP4B BGN CNOT6 VSTM4 NEO1 UBTF UGP2 KCTD15 NPAS2 CLDND1 CACHD1 TEX15 HIPK3 MAPK3 | 2.18e-04 | 563 | 265 | 16 | M15103 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ATP6V1C1 ASPN ACTA1 ACTA2 DGKA TSC2 CCDC178 WARS2 TIAM2 GHR FER TLN2 NMT1 NPC1 DOCK2 CRISPLD2 COL6A3 SIN3B IQCH HTRA2 POLR2J3 MYO1H MRPL33 RUFY1 KRIT1 TK2 | 2.22e-04 | 1198 | 265 | 26 | MM1062 |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP | 2.24e-04 | 159 | 265 | 8 | M12138 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 2.26e-04 | 85 | 265 | 6 | M10575 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | PDXDC1 CYP2C9 PRAMEF5 ESRRA DGKA PSMD11 UBTF NFKB1 PRAMEF6 NAA15 ANPEP PRAMEF19 ENC1 BTBD17 ID2 PRAMEF18 GSPT1 IFNAR2 TPK1 CAPN7 SORBS3 | 2.30e-04 | 871 | 265 | 21 | MM1005 |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 2.34e-04 | 55 | 265 | 5 | M2043 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ATP6V1C1 ASPN ACTA1 ACTA2 DGKA TSC2 CCDC178 WARS2 TIAM2 GHR FER TLN2 NMT1 NPC1 DOCK2 CRISPLD2 COL6A3 SIN3B IQCH HTRA2 MYO1H MRPL33 RUFY1 KRIT1 TK2 | 2.39e-04 | 1136 | 265 | 25 | M2247 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.47e-04 | 250 | 265 | 10 | M11318 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | RPS6KA3 HSPH1 MARCHF6 ACTA2 DGKA DARS1 TEX10 ADD1 DNAJC10 SACS ERAP2 UBTF RAB3GAP2 KCNAB1 MRPL33 BABAM2 WDR59 GSPT1 TRAK1 HIPK3 LRPPRC ZNHIT6 PDE12 CAPN7 MTR CALCRL | 2.76e-04 | 1215 | 265 | 26 | M41122 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 2.83e-04 | 208 | 265 | 9 | M39233 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 2.99e-04 | 256 | 265 | 10 | M10952 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | EREG ACTA2 ACTC1 BGN ITPR1 GHR VSTM4 NEO1 MAGED2 GLI2 NAV2 PYGL NPC1 DOCK2 COL6A3 LRCH2 ANPEP RASA3 ID2 IDH1 TEX15 RESF1 PDE8B VCAN MTR DCLK1 | 1.15e-06 | 740 | 256 | 26 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | ACTA2 ACTC1 P4HA3 BGN GHR VSTM4 NEO1 MAGED2 GLI2 NAV2 KCNAB1 AK4 ABCD2 NPC1 COL6A3 LRCH2 ANPEP RASA3 CACHD1 IDH1 TEX15 RESF1 PDE8B VCAN MTR DCLK1 MYBPC1 | 1.42e-06 | 797 | 256 | 27 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | ASPN USP11 INPP5D ACTC1 P4HA3 PSME2 SLC30A4 INPP4B GGT1 GHR FAT1 MAGED2 GLI2 PYGL PLD2 DNASE1L1 RNASEH2B CACHD1 FAM171B TPK1 ARHGAP1 FRK PTPDC1 CADPS VCAN TET1 SORBS3 IPO13 HBZ DCLK1 CDH13 CYTH4 MYBPC1 | 9.75e-06 | 1208 | 256 | 33 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | ACTC1 GHR GLI2 RAB3GAP2 UGP2 COL6A3 ARSJ TEX15 FAM171B FRK PTPDC1 CADPS TMLHE MTR CALCRL HBZ | 2.13e-05 | 388 | 256 | 16 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | RPS6KA3 ACTA2 ACTC1 P4HA3 BGN GHR NEO1 GLI2 NAV2 KCNAB1 PYGL AK4 NPC1 COL6A3 LRCH2 ANPEP RASA3 CACHD1 TEX15 RESF1 PDE8B VCAN MTR DCLK1 | 3.85e-05 | 797 | 256 | 24 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.86e-05 | 168 | 256 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 7.58e-05 | 182 | 256 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | TRPM7 ASPN ACTA2 PDE10A ADD1 BGN CNOT6 UBTF ASPM NAV2 CRISPLD2 NSUN4 NAA15 ABCC5 FAM171B SMC2 IFNAR2 RESF1 TMLHE TET1 CALCRL DCLK1 MYBPC1 | 9.31e-05 | 790 | 256 | 23 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | DPY19L3 ACTC1 ADGRV1 GHR NEO1 STXBP1 GLI2 RAB3GAP2 UGP2 COL6A3 ARSJ LRCH2 ANK2 TEX15 FAM171B FRK PTPDC1 CADPS TMLHE MTR CALCRL HBZ DCLK1 | 9.48e-05 | 791 | 256 | 23 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.74e-04 | 97 | 256 | 7 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.81e-04 | 24 | 256 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 1.83e-04 | 165 | 256 | 9 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.83e-04 | 130 | 256 | 8 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | RPS6KA3 INPP4B TIAM2 TMTC3 GLI2 KCNAB1 TBX4 CYP26B1 SOSTDC1 CACHD1 FAM171B CADPS VCAN DCLK1 | 2.09e-04 | 377 | 256 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | NEO1 NAV2 LRCH2 ANPEP RASA3 CACHD1 IDH1 RESF1 PDE8B MTR DCLK1 | 2.48e-04 | 251 | 256 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_100 | 2.50e-04 | 26 | 256 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_100_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | STK17B ACTC1 TIAM2 GHR NPHS2 GLI2 SYDE2 NAV2 AK4 USP13 ANPEP RASA3 ID2 CACHD1 TEX15 RESF1 CADPS VCAN SORBS3 MTR HBZ DCLK1 MYBPC1 | 2.65e-04 | 849 | 256 | 23 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | RELN ASPN ESRRG ACTA1 ACTA2 ACTC1 P4HA3 SLFN5 GGT1 BGN ITPR1 KCNAB1 PYGL ANPEP TCN2 SYNE1 ID2 SOSTDC1 FRK CD9 LACTB2 VCAN CALCRL DCLK1 | 2.66e-04 | 905 | 256 | 24 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | ASPN ACTA1 ACTA2 ADD1 GGT1 BGN UBTF ASPM NAV2 CNDP1 CRISPLD2 NSUN4 NAA15 ARSJ FAM171B SMC2 ARL4C RESF1 TMLHE TET1 CALCRL DCLK1 | 2.79e-04 | 797 | 256 | 22 | gudmap_developingGonad_P2_epididymis_1000 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ASPN ACTA2 ACTC1 BGN ITPR1 FAT1 CRISPLD2 COL6A3 TBX4 ANK2 SYNE1 SOSTDC1 ADAMTSL3 | 1.58e-10 | 191 | 267 | 13 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | ACTA2 PDE10A INPP4B ITPR1 GLI2 CRISPLD2 COL6A3 LRCH2 ADAMTSL3 ADAM12 DCLK1 CDH13 | 1.49e-09 | 186 | 267 | 12 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | ASPN ACTA2 ACTC1 BGN GHR FAT1 CRISPLD2 COL6A3 SYNE1 SOSTDC1 ADAMTSL3 VCAN | 3.39e-09 | 200 | 267 | 12 | 5ed4261157cd51109b314818133ac3a0d34ee5fa |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ASPN ACTA2 ACTC1 BGN ITPR1 FAT1 CRISPLD2 DRD1 SYNE1 SOSTDC1 ADAMTSL3 PDE8B | 3.39e-09 | 200 | 267 | 12 | 77631c471cc5d453a749784f838cfa6408caf09b |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ACTA2 INPP4B BGN FAT1 CRISPLD2 TBX4 LRCH2 NRCAM PCDHA3 ADAMTSL3 PDE8B | 1.79e-08 | 186 | 267 | 11 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ASPN ACTA2 BGN GHR FAT1 CRISPLD2 COL6A3 TBX4 SYNE1 SOSTDC1 ADAMTSL3 | 2.11e-08 | 189 | 267 | 11 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ACTA2 INPP4B BGN GHR FAT1 CRISPLD2 COL6A3 TBX4 NRCAM ADAMTSL3 PDE8B | 2.23e-08 | 190 | 267 | 11 | 4eb92aef1ee868f4537483d19014d947b7684612 |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ACTA2 INPP4B BGN GHR FAT1 CRISPLD2 COL6A3 TBX4 NRCAM ADAMTSL3 PDE8B | 2.23e-08 | 190 | 267 | 11 | 7be4341e2909101d756f14031c21e705eb45e69a |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ASPN ACTA2 ACTC1 BGN GHR FAT1 COL6A3 TBX4 SYNE1 SOSTDC1 ADAMTSL3 | 2.35e-08 | 191 | 267 | 11 | 08042952431ca1a6fd7dfc13f36eb28643979598 |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | ACTA2 PDE10A INPP4B GLI2 CRISPLD2 COL6A3 ARSJ ADAMTSL3 ADAM12 DCLK1 CDH13 | 2.35e-08 | 191 | 267 | 11 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | ASPN ACTA2 P4HA3 BGN GHR TMTC3 CRISPLD2 COL6A3 TBX4 ANK2 ENC1 | 2.35e-08 | 191 | 267 | 11 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ATR ADGRV1 CNOT6 DLG1 PDS5A DNAJC16 GSPT1 FRK LRPPRC PBRM1 DTWD2 | 2.62e-08 | 193 | 267 | 11 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | INPP4B GHR GLI2 NAV2 CRISPLD2 COL6A3 ANK2 NRCAM ADAM12 VCAN CDH13 | 3.41e-08 | 198 | 267 | 11 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BGN GHR VSTM4 NAV2 CRISPLD2 COL6A3 ANK2 SYNE1 ADAMTSL3 VCAN DCLK1 | 3.78e-08 | 200 | 267 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-08 | 161 | 267 | 10 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-08 | 161 | 267 | 10 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.60e-07 | 182 | 267 | 10 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.86e-07 | 185 | 267 | 10 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.96e-07 | 186 | 267 | 10 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | ACTA2 INPP4B GHR GLI2 NAV2 NPAS2 CRISPLD2 COL6A3 RASA3 ADAM12 | 2.06e-07 | 187 | 267 | 10 | 76bfe8c42430a230a8bdf299575c444fb7780f24 |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.16e-07 | 188 | 267 | 10 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PDE10A GLI2 NPAS2 CRISPLD2 COL6A3 ANK2 NRCAM RASA3 ADAM12 VCAN | 2.38e-07 | 190 | 267 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | ACTA2 GHR GLI2 CRISPLD2 COL6A3 ANK2 ADAMTSL3 VCAN DCLK1 CDH13 | 2.38e-07 | 190 | 267 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.38e-07 | 190 | 267 | 10 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ASPN ACTA2 BGN ITPR1 FAT1 KCNAB1 CRISPLD2 COL6A3 ADAMTSL3 VCAN | 2.50e-07 | 191 | 267 | 10 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ACTA2 INPP4B BGN GLI2 KCNAB1 CRISPLD2 COL6A3 LRCH2 SORBS3 CDH13 | 2.50e-07 | 191 | 267 | 10 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | ATP6V1C1 STK17B ACTA2 BGN CRISPLD2 SLC34A2 ADAM12 VCAN CDH13 PDCD1LG2 | 2.50e-07 | 191 | 267 | 10 | 80d30d8eedb4c70b58440646325bc04c5700803e |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ITGA2 INPP4B GHR GLI2 NAV2 CRISPLD2 COL6A3 ANK2 ADAMTSL3 CDH13 | 2.63e-07 | 192 | 267 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.89e-07 | 194 | 267 | 10 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | INPP4B GLI2 NAV2 DENND5A CRISPLD2 COL6A3 RASA3 SYNE1 ADAM12 DCLK1 | 3.49e-07 | 198 | 267 | 10 | a860246bcea847249a78fd2e86ed8e04371060db |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.49e-07 | 198 | 267 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-07 | 198 | 267 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.49e-07 | 198 | 267 | 10 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | ACTA2 INPP4B BGN FAT1 CRISPLD2 TBX4 LRCH2 NRCAM ADAMTSL3 PDE8B | 3.83e-07 | 200 | 267 | 10 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ACTA2 INPP4B BGN FAT1 CRISPLD2 TBX4 LRCH2 NRCAM ADAMTSL3 PDE8B | 3.83e-07 | 200 | 267 | 10 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | GHR VSTM4 NAV2 CRISPLD2 COL6A3 ANK2 SYNE1 ADAMTSL3 VCAN DCLK1 | 3.83e-07 | 200 | 267 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-07 | 200 | 267 | 10 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ACTA2 INPP4B BGN FAT1 CRISPLD2 TBX4 LRCH2 NRCAM ADAMTSL3 PDE8B | 3.83e-07 | 200 | 267 | 10 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 INPP4B BGN ITPR1 FAT1 KCNAB1 CRISPLD2 DRD1 SYNE1 | 3.83e-07 | 200 | 267 | 10 | a3a1e35934d676c39f917652e50c502cb2f613c1 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ACTA2 ACTC1 BGN FAT1 KCNAB1 CRISPLD2 DRD1 SYNE1 ADAMTSL3 PDE8B | 3.83e-07 | 200 | 267 | 10 | b22cae282591d8dead9869c2adbb9632615f50f7 |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ASPN ACTA2 BGN GHR FAT1 CRISPLD2 COL6A3 SYNE1 SOSTDC1 ADAMTSL3 | 3.83e-07 | 200 | 267 | 10 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-06 | 175 | 267 | 9 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.54e-06 | 181 | 267 | 9 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.69e-06 | 183 | 267 | 9 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 267 | 9 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 184 | 267 | 9 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.85e-06 | 185 | 267 | 9 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.02e-06 | 187 | 267 | 9 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 189 | 267 | 9 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 189 | 267 | 9 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 189 | 267 | 9 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-06 | 189 | 267 | 9 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 189 | 267 | 9 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 189 | 267 | 9 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 189 | 267 | 9 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-06 | 189 | 267 | 9 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 189 | 267 | 9 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 190 | 267 | 9 | ba61f04fd38efae01f721ba616252d1372ff1002 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 190 | 267 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 190 | 267 | 9 | 5a37568000dfc33fcbb59b578c1963fb7cf872ec | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 191 | 267 | 9 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 191 | 267 | 9 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-06 | 191 | 267 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 191 | 267 | 9 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.40e-06 | 191 | 267 | 9 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 191 | 267 | 9 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 191 | 267 | 9 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 192 | 267 | 9 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.51e-06 | 192 | 267 | 9 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 193 | 267 | 9 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.61e-06 | 193 | 267 | 9 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.61e-06 | 193 | 267 | 9 | e787e618f6e8a1e22be366ce606bf78831b60a90 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.73e-06 | 194 | 267 | 9 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 2.73e-06 | 194 | 267 | 9 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.73e-06 | 194 | 267 | 9 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 2.73e-06 | 194 | 267 | 9 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 194 | 267 | 9 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 194 | 267 | 9 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-06 | 194 | 267 | 9 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-06 | 195 | 267 | 9 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 195 | 267 | 9 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.85e-06 | 195 | 267 | 9 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-06 | 195 | 267 | 9 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.85e-06 | 195 | 267 | 9 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.85e-06 | 195 | 267 | 9 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-06 | 195 | 267 | 9 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 196 | 267 | 9 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-06 | 196 | 267 | 9 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 196 | 267 | 9 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.97e-06 | 196 | 267 | 9 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 196 | 267 | 9 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-06 | 196 | 267 | 9 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | P15-Mesenchymal-myocytic_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.97e-06 | 196 | 267 | 9 | 41ae5b0d81ad09a6663335d899b4a1e4976c3b62 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.97e-06 | 196 | 267 | 9 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.97e-06 | 196 | 267 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-06 | 197 | 267 | 9 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.09e-06 | 197 | 267 | 9 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-06 | 197 | 267 | 9 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-06 | 197 | 267 | 9 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-06 | 197 | 267 | 9 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| Computational | Genes in the cancer module 387. | 9.35e-05 | 49 | 164 | 6 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 1.17e-04 | 51 | 164 | 6 | MODULE_329 | |
| Computational | Muscle genes. | 2.28e-04 | 37 | 164 | 5 | MODULE_512 | |
| Drug | AC1L22FJ | PDXDC1 PDS5B CYP2C9 ESRRA ESRRG RMC1 NAA15 HTRA2 IDH1 GSPT1 ARHGAP1 PBRM1 NGLY1 MAPK3 | 2.03e-07 | 213 | 263 | 14 | CID000013766 |
| Drug | AC1L2DAI | HSPH1 ACTA1 ACTA2 ACTC1 ERAP2 ANPEP HTRA2 SLC34A2 ABCC5 APOB EGF LNPEP TK2 VCAN HBZ CDH13 | 5.60e-07 | 304 | 263 | 16 | CID000004984 |
| Drug | magnesium | TRPM7 RPS6KA3 BCKDK ACTA1 ACTA2 ACTC1 DGKA DARS1 ITGA2 ADGRV1 PDE10A POLA2 WARS2 ADCY9 INPP4B SARS1 UGP2 AK4 DENND5A PLD2 DNASE1L1 ANPEP WEE1 POLR2L DNM1L IDH1 CRAT MYLK2 KRIT1 RIT2 TPK1 ARHGAP1 PTPA TK2 VCAN MTR PC | 5.95e-07 | 1325 | 263 | 37 | CID000000888 |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | ESRRG PDS5A TLN2 PLD2 NPAS2 SLC34A2 WDR59 TAF6L ARHGAP1 PDE12 LNPEP TK2 CNGB3 | 5.95e-07 | 199 | 263 | 13 | 4087_DN |
| Drug | felodipine | CYP3A7 EREG CYP2C9 CYP26A1 PDE10A ITPR1 FER CACNA1F CYP26B1 MYLK2 EGF PDE8B | 6.71e-07 | 169 | 263 | 12 | CID000003333 |
| Drug | arabinosyladenine | ACTA1 ACTA2 ACTC1 DARS1 PDE10A F8 WARS2 ADCY9 ITPR1 SARS1 MYLK3 UBTF NFKB1 PYGL AK4 DENND5A PLD2 DRD1 POLR2L IDH1 PTPA TK2 PDE8B TET1 MAPK3 MYBPC1 | 9.19e-07 | 762 | 263 | 26 | CID000000191 |
| Drug | foscarnet | ACTA1 ACTA2 ACTC1 ITGA2 POLA2 F8 GP1BA COL6A3 SLC34A2 WDR19 CD9 TK2 | 2.31e-06 | 190 | 263 | 12 | CID000003414 |
| Drug | caffeine | NAT2 CYP3A7 EREG CYP2C9 CYP26A1 PDE10A ADCY9 ITPR1 PYGL PLD2 CACNA1F DRD1 CYP26B1 SYNE1 MYLK2 KRIT1 PTPA EGF TK2 PDE8B MYBPC1 | 2.67e-06 | 562 | 263 | 21 | CID000002519 |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | ATP6V1C1 TOGARAM1 IFT46 DLG1 NMT1 ENC1 TRAK1 WDR19 HIPK3 PDE12 CD9 LNPEP | 3.03e-06 | 195 | 263 | 12 | 3001_DN |
| Drug | Fluorometholone [426-13-1]; Down 200; 10.6uM; PC3; HT_HG-U133A | INCENP ITFG2 STK17B F8 ERAP2 DLG1 GPR3 ENC1 ID2 PDE12 BTBD7 VCAN | 3.36e-06 | 197 | 263 | 12 | 5771_DN |
| Drug | chelerythrine | EREG TRPM7 ACTA1 ACTA2 ACTC1 DGKA ADCY9 ITPR1 PLD2 ANPEP BABAM2 MYLK2 KRIT1 PTPA EGF MAPK3 | 4.52e-06 | 357 | 263 | 16 | CID000002703 |
| Drug | manganese | NAT2 TRPM7 ACTA1 ACTA2 ACTC1 DARS1 ITGA2 POLA2 ADCY9 ITPR1 GHR NFKB1 PYGL DNASE1L1 CNDP1 CACNA1F POLR2L IDH1 CRAT KRIT1 PTPA MAPK3 CALCRL PC HBZ | 5.79e-06 | 791 | 263 | 25 | CID000023930 |
| Drug | copper carbonate | 6.04e-06 | 4 | 263 | 3 | CID000014452 | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | PDS5B ITFG2 ITGA2 MAGEF1 UBTF CRISPLD2 ARL4C PTPA EGF VCAN CNGB3 | 1.26e-05 | 188 | 263 | 11 | 2079_DN |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A | RELN NPHS2 CRISPLD2 ADAM12 THAP9 WDR59 ARL4C TK2 PDE8B VCAN SORBS3 | 1.33e-05 | 189 | 263 | 11 | 3072_UP |
| Drug | procymidone | 1.35e-05 | 155 | 263 | 10 | ctd:C035988 | |
| Drug | NSC759576 | CYP3A7 CYP2C9 DGKA ADCY9 ITPR1 SACS NFKB1 CNGB1 CACNA1F APOB TRAK1 | 1.47e-05 | 191 | 263 | 11 | CID000003075 |
| Drug | sulfitocobalamin | 1.50e-05 | 5 | 263 | 3 | CID006440950 | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; PC3; HT_HG-U133A | ADCY9 ADD1 BGN NPHS2 RAB3GAP2 KCNAB1 DLG1 CNGB1 GP1BA SOSTDC1 VCAN | 1.86e-05 | 196 | 263 | 11 | 6601_UP |
| Drug | monomethyl phthalate | ATR ASPN INPP5D ESRRA RPS6KA3 BCKDK ACTA1 ITPR1 GHR GLI2 ASPM FER DLG1 ECEL1 DRD1 ANK2 ANPEP WEE1 ABCC5 SLU7 APOB PBRM1 CD9 CADPS LNPEP PC HBZ | 1.88e-05 | 957 | 263 | 27 | ctd:C517284 |
| Drug | Methylatropine nitrate [52-88-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.96e-05 | 197 | 263 | 11 | 7253_DN | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | ACTA1 MARCHF6 ACTC1 ITPR1 KCNAB1 DRD1 RASA3 GSPT1 TRAK1 HIPK3 PDE8B | 1.96e-05 | 197 | 263 | 11 | 5402_UP |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A | PDS5B UBTF FER KCNAB1 PDS5A CRISPLD2 ENC1 KRIT1 TRAK1 VCAN MTR | 1.96e-05 | 197 | 263 | 11 | 4216_DN |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | ITFG2 ACTC1 ITPR1 KCTD15 DRD1 UBR4 TEX15 ADAM12 WDR59 EGF CYTH4 | 2.05e-05 | 198 | 263 | 11 | 5592_UP |
| Drug | phenylarsine oxide | TRPM7 ACTA1 ACTA2 ACTC1 NFKB1 PLD2 ABCC5 DNM1L APOB PTPA EGF TK2 MAPK3 | 2.06e-05 | 275 | 263 | 13 | CID000004778 |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; PC3; HT_HG-U133A | EREG STK17B ACTA1 SLC30A4 KCNAB1 RASA3 DNAJC16 CRAT GSPT1 TRAK1 ARHGAP1 | 2.15e-05 | 199 | 263 | 11 | 3730_UP |
| Drug | AC1O5LBK | ACTC1 TGM6 ADD1 NFKB1 ABCD2 NPC1 SOSTDC1 APOB IDH1 EGF TK2 MAPK3 | 2.68e-05 | 242 | 263 | 12 | CID006436256 |
| Drug | eye gene | ACTA1 ACTA2 ACTC1 TSC2 ADCY9 ADD1 MYLK3 UBTF PYGL PLD2 NPAS2 DRD1 MYLK2 EGF MAPK3 | 2.83e-05 | 369 | 263 | 15 | CID000004782 |
| Drug | 4-keto-retinal | 2.97e-05 | 6 | 263 | 3 | CID000135007 | |
| Drug | bromoacetone | 2.97e-05 | 6 | 263 | 3 | CID000011715 | |
| Drug | everolimus | 2.98e-05 | 136 | 263 | 9 | CID006442177 | |
| Drug | phorbol acetate myristate | EREG STK17B RPS6KA1 ESRRA RPS6KA3 ESRRG HSPH1 ACTA1 ACTA2 ACTC1 DGKA TSC2 ITGA2 ADCY9 ITPR1 GHR MYLK3 NFKB1 PLD2 GP1BA CACNA1F ANPEP APOB GSPT1 MYLK2 KRIT1 WDR19 PTPA EGF CD9 TK2 VCAN MAPK3 CALCRL | 3.35e-05 | 1399 | 263 | 34 | CID000004792 |
| Drug | D-myo-inositol-1,4,5-triphosphate | EREG INPPL1 ACTA1 MARCHF6 ACTA2 ACTC1 DGKA ADCY9 INPP4B ITPR1 PYGL PLD2 CACNA1F ANK2 RASA3 MYLK2 KRIT1 EGF MAPK3 | 3.72e-05 | 568 | 263 | 19 | CID000000806 |
| Drug | 2,4,4'-trichlorobiphenyl | ATR INCENP RPS6KA3 ACTC1 TGM6 POLA2 ITPR1 NUP205 TMTC3 SACS GLI2 ASPM NAV2 KCTD15 TLN2 TMEM181 CACNA1F COL6A3 ARSJ DPP10 MYO1H ENC1 SOSTDC1 SMC2 ADAM12 BABAM2 KIF20B MYLK2 RIT2 ZNHIT6 PBRM1 EGF MAPK3 CDH8 | 3.98e-05 | 1411 | 263 | 34 | ctd:C081766 |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | ACTA1 ACTA2 ACTC1 DGKA PDE10A ADCY9 ITPR1 NEO1 CNGB1 CACNA1F ABCC5 MYLK2 KRIT1 PTPA EGF PDE8B CNGB3 MAPK3 HBZ | 4.59e-05 | 577 | 263 | 19 | CID000000295 |
| Drug | 5-(2-iodovinyl)-2'-deoxyuridine | 4.69e-05 | 18 | 263 | 4 | CID006438371 | |
| Drug | CoA group | NAT2 CYP2C9 BCKDK ACTA1 ACTA2 ACTC1 P4HA3 GGT1 GHR NMT1 NPC1 APOB IDH1 CRAT PC PIGM | 4.83e-05 | 433 | 263 | 16 | CID000000317 |
| Drug | morin hydrate | 4.97e-05 | 57 | 263 | 6 | CID003365422 | |
| Drug | ethylnylestradiol | CYP3A7 EREG CYP2C9 TRPM7 ESRRA CYP26A1 ESRRG ACTA1 ACTA2 ACTC1 TSC2 ADCY9 GGT1 BGN CNOT6 GHR UBTF NFKB1 GP1BA DRD1 CYP26B1 TCN2 ID2 SLC34A2 APOB CRHBP EGF CD9 TK2 MAPK3 HBZ | 5.35e-05 | 1251 | 263 | 31 | CID000003285 |
| Drug | PD 0325901 | 5.46e-05 | 114 | 263 | 8 | ctd:C506614 | |
| Drug | dihydrocytochalasin B | 5.49e-05 | 58 | 263 | 6 | CID000003064 | |
| Drug | AC1O3GBZ | 5.57e-05 | 36 | 263 | 5 | CID006327751 | |
| Drug | 5-iodouracil | 5.57e-05 | 36 | 263 | 5 | CID000069672 | |
| Drug | pentoxifylline | ASPN ACTA1 ACTA2 ACTC1 PDE10A MYLK3 NFKB1 PLD2 PBRM1 CD9 PDE8B NGLY1 HBZ | 5.79e-05 | 304 | 263 | 13 | CID000004740 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | ATR INCENP RPS6KA3 ACTC1 TGM6 POLA2 ITPR1 NUP205 TMTC3 SACS GLI2 ASPM NAV2 KCTD15 TLN2 TMEM181 CACNA1F COL6A3 ARSJ DPP10 MYO1H ENC1 SOSTDC1 SMC2 ADAM12 BABAM2 KIF20B MYLK2 RIT2 ZNHIT6 PBRM1 EGF MAPK3 CDH8 | 6.03e-05 | 1441 | 263 | 34 | ctd:C009828 |
| Drug | AC1L1KC5 | EREG STK17B ACTA1 ACTA2 ACTC1 PTDSS2 ADCY9 ITPR1 MYLK3 DNAJC10 SACS PLD2 CACNA1F MYLK2 KRIT1 RIT2 EGF MAPK3 | 6.39e-05 | 541 | 263 | 18 | CID000005428 |
| Drug | troglitazone | CYP3A7 EREG CYP2C9 ESRRA CYP26A1 HSPH1 ACTA2 ITGA2 POLA2 NFKB1 ASPM DLG1 PYGL ABCD2 ANPEP WEE1 ID2 SLC34A2 IDH1 SMC2 CRAT KIF20B TRAK1 SGK2 HIPK3 FRK CD9 LACTB2 VCAN MAPK3 PC DCLK1 | 6.93e-05 | 1329 | 263 | 32 | ctd:C057693 |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | ITFG2 STK17B INPP5D PEX10 ITPR1 DNAJC10 KCTD15 DLG1 PDS5A WDR59 | 7.02e-05 | 188 | 263 | 10 | 2161_DN |
| Drug | KT5720 | 7.34e-05 | 189 | 263 | 10 | CID000003844 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | ATR POLA2 MAGEF1 ITPR1 NPAS2 HTRA2 WDR19 ARHGAP1 SORBS3 CFAP44 | 8.01e-05 | 191 | 263 | 10 | 4289_DN |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | EREG ACTA1 ACTA2 ACTC1 DGKA PSMC4 ADCY9 PLD2 MYLK2 KRIT1 PTPA EGF MYBPC1 | 8.03e-05 | 314 | 263 | 13 | CID000003542 |
| Drug | cyclobuta | 8.18e-05 | 8 | 263 | 3 | CID000122100 | |
| Drug | AC1NUVX5 | 8.18e-05 | 8 | 263 | 3 | CID005461894 | |
| Drug | 6-methoxypurine | 8.18e-05 | 8 | 263 | 3 | CID000070632 | |
| Drug | hydroxyl radicals | CYP3A7 ATP6V1C1 CYP2C9 USP11 INPPL1 CYP26A1 ITGA2 PDE10A F8 INPP4B GGT1 NFKB1 UGP2 PLD2 CNDP1 COL6A3 EFL1 USP13 CYP26B1 ANPEP WEE1 DNM1L IDH1 PPEF1 CRAT PTPDC1 PTPA EGF MTR MAPK3 CALCRL PC | 8.20e-05 | 1341 | 263 | 32 | CID000000961 |
| Drug | FIGLU | 8.27e-05 | 39 | 263 | 5 | CID000000909 | |
| Drug | DFMO | 8.28e-05 | 155 | 263 | 9 | CID000003009 | |
| Drug | C75; Down 200; 10uM; MCF7; HT_HG-U133A | ITFG2 CYP26A1 KCNAB1 COL6A3 GSPT1 HIPK3 TAF6L PDE12 EGF BTBD7 | 8.74e-05 | 193 | 263 | 10 | 6394_DN |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | ATP6V1C1 ITFG2 CYP26A1 ACTA2 PEX10 MAGED2 DLG1 ARHGAP1 BTBD7 POFUT1 | 9.12e-05 | 194 | 263 | 10 | 2293_DN |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | ESRRG ACTC1 ADCY9 KCNAB1 DOCK1 HIPK3 ARHGAP1 BTBD7 VCAN SORBS3 | 9.12e-05 | 194 | 263 | 10 | 4335_DN |
| Drug | butylparaben | 9.14e-05 | 157 | 263 | 9 | ctd:C038091 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | PEX10 ITGA2 MAGEF1 ADD1 GHR MAGED2 IFNAR2 ARL4C SORBS3 POFUT1 | 9.52e-05 | 195 | 263 | 10 | 6971_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA | ATP6V1C1 STK17B MAGEF1 WARS2 UBTF CRAT HIPK3 TAF6L ARHGAP1 PC | 9.52e-05 | 195 | 263 | 10 | 989_DN |
| Drug | 1,6-di-o-phosphonohexopyranose | 9.60e-05 | 64 | 263 | 6 | CID000000737 | |
| Drug | Equilin sodium sulfate | 9.60e-05 | 64 | 263 | 6 | CID000027993 | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.93e-05 | 196 | 263 | 10 | 5669_DN | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; HL60; HT_HG-U133A | INPP5D ADCY9 RAB3GAP2 CRAT WDR59 TAF6L ARHGAP1 TK2 VCAN POFUT1 | 9.93e-05 | 196 | 263 | 10 | 2442_UP |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; HL60; HT_HG-U133A | DSTYK KCNAB1 DDX49 HTRA2 TRAK1 ARHGAP1 ARL4C LNPEP BTBD7 VCAN | 1.04e-04 | 197 | 263 | 10 | 3070_DN |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A | ITFG2 ESRRA CYP26A1 ITPR1 PLD2 KRIT1 TAF6L BTBD7 SORBS3 POFUT1 | 1.04e-04 | 197 | 263 | 10 | 2301_DN |
| Drug | Clidinium bromide [3485-62-9]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.04e-04 | 197 | 263 | 10 | 4499_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A | ITFG2 STK17B INPPL1 ADCY9 TLN2 DDX49 SLC34A2 CDC42BPB KRIT1 CNGB3 | 1.04e-04 | 197 | 263 | 10 | 4084_DN |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | PDS5B TSC2 DDB1 MAGEF1 KCTD15 NRCAM PBRM1 SORBS3 MAPK3 ZNF654 | 1.08e-04 | 198 | 263 | 10 | 1135_DN |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | ITFG2 KCNAB1 UBIAD1 DOCK1 TRAK1 WDR19 HIPK3 PTPA BTBD7 POFUT1 | 1.08e-04 | 198 | 263 | 10 | 7484_DN |
| Drug | rhein | 1.08e-04 | 22 | 263 | 4 | ctd:C020491 | |
| Drug | tamoxifen aziridine | 1.08e-04 | 22 | 263 | 4 | CID003033894 | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 263 | 10 | 6775_UP | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | INCENP ITFG2 STK17B NPHS2 ERAP2 RAB3GAP2 PDS5A SGK2 ARHGAP1 CNGB3 | 1.13e-04 | 199 | 263 | 10 | 6674_DN |
| Drug | dicyclohexyl phthalate | OPN4 ATR ASPN INPP5D ACTA1 ACTC1 ITPR1 GHR DLG1 TLN2 COL6A3 DRD1 ANK2 ANPEP WEE1 ABCC5 APOB PBRM1 CD9 CADPS LNPEP PC HBZ | 1.16e-04 | 836 | 263 | 23 | ctd:C036042 |
| Drug | Dequalinium-14 | 1.22e-04 | 9 | 263 | 3 | CID000002497 | |
| Drug | So324 | 1.22e-04 | 9 | 263 | 3 | CID000462261 | |
| Drug | microcystin-LR | 1.30e-04 | 129 | 263 | 8 | CID000445433 | |
| Drug | enzacamene | 1.30e-04 | 129 | 263 | 8 | ctd:C038939 | |
| Drug | acetylsulfapyridine | 1.33e-04 | 2 | 263 | 2 | CID000058638 | |
| Drug | 1-benzosuberone | 1.33e-04 | 2 | 263 | 2 | CID000070003 | |
| Drug | topsentin | 1.33e-04 | 2 | 263 | 2 | CID000072457 | |
| Drug | tert-butyl hydroperoxide | ATP6V1C1 HSPH1 DARS1 PSMD11 ITGA2 ADCY9 NUP205 NFKB1 PYGL NPC1 DOCK2 CRISPLD2 NAA15 ANPEP WEE1 IDH1 CRAT GSPT1 TRAK1 CD9 CAPN7 VCAN MAPK3 HBZ | 1.36e-04 | 902 | 263 | 24 | CID000006410 |
| Drug | Factrel | 1.45e-04 | 246 | 263 | 11 | CID000036523 | |
| Drug | AC1L1GZB | 1.46e-04 | 167 | 263 | 9 | CID000003908 | |
| Drug | Metribolone | PDXDC1 PDS5B ATR DARS1 ITGA2 MAGED2 RMC1 NAA15 HTRA2 IDH1 GSPT1 ARHGAP1 NGLY1 MAPK3 | 1.56e-04 | 382 | 263 | 14 | ctd:D015741 |
| Drug | caged ATP | 1.58e-04 | 70 | 263 | 6 | CID000123806 | |
| Drug | 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride | 1.72e-04 | 10 | 263 | 3 | ctd:C508504 | |
| Drug | OP-41483 | 1.72e-04 | 10 | 263 | 3 | CID006436122 | |
| Drug | sulphoxide | 1.73e-04 | 101 | 263 | 7 | CID000008442 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.75e-04 | 171 | 263 | 9 | 5208_UP | |
| Drug | LY294002 | EREG RPS6KA1 INPPL1 ESRRA RPS6KA3 ESRRG ACTA1 ACTA2 ACTC1 TSC2 ITGA2 ITPR1 NFKB1 PLD2 ADAM12 KRIT1 SGK2 PTPA EGF CNGB3 MAPK3 | 1.75e-04 | 748 | 263 | 21 | CID000003973 |
| Drug | orthovanadate | ATP6V1C1 EREG TRPM7 ACTC1 PDE10A ADCY9 PYGL PLD2 ABCC5 CRAT PTPA EGF CD9 PDE8B MAPK3 | 1.77e-04 | 435 | 263 | 15 | CID000061672 |
| Drug | triadimefon | EREG ASPN CYP26A1 ACTA2 DARS1 PSMD11 ADGRV1 ATG16L2 CYP26B1 ID2 EGF CD9 CAPN7 PC | 1.88e-04 | 389 | 263 | 14 | ctd:C032910 |
| Drug | AC1L1BDQ | 1.91e-04 | 173 | 263 | 9 | CID000001394 | |
| Disease | body weight | PDXDC1 RELN DPY19L3 AMZ1 ESRRG ADGRV1 TEX10 ADCY9 DNAH14 ITPR1 GHR KCTD15 TLN2 UBIAD1 RMC1 NPC1 DOCK1 TBX4 ARSJ NRCAM ADAMTSL3 WDR59 RIT2 SGK2 TNNI3K CADPS MAPK3 METTL15 CDH13 | 2.61e-06 | 1261 | 260 | 29 | EFO_0004338 |
| Disease | neuroimaging measurement, brain volume measurement | PDXDC1 ATR AMZ1 DSTYK FAM171B MYLK2 RIT2 PBRM1 DTWD2 VCAN CATSPERB CALCRL | 9.99e-06 | 286 | 260 | 12 | EFO_0004346, EFO_0006930 |
| Disease | HWESASXX measurement | 2.31e-05 | 7 | 260 | 3 | EFO_0021147 | |
| Disease | cortical surface area measurement | RELN STK17B AMZ1 ADGRV1 WARS2 CNOT6 VSTM4 NEO1 UBTF DSTYK RAB3GAP2 NFKB1 KCNJ11 NAV2 TLN2 CACHD1 ADAMTSL3 ADAM12 KIF20B RIT2 ARHGAP1 ARL4C LACTB2 CADPS VCAN CALCRL PC DCLK1 | 2.43e-05 | 1345 | 260 | 28 | EFO_0010736 |
| Disease | Moyamoya disease (implicated_via_orthology) | 3.67e-05 | 8 | 260 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 3.67e-05 | 8 | 260 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 3.67e-05 | 8 | 260 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 3.67e-05 | 8 | 260 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TRPM7 VSTM4 FAT1 MYLK3 SACS ABCD2 ANK2 NRCAM TCN2 SYNE1 ABCC5 APOB IDH1 ADAMTSL3 TNNI3K ZNHIT6 CD9 DCLK1 | 5.77e-05 | 702 | 260 | 18 | C0009402 |
| Disease | Striatal degeneration, autosomal dominant | 7.73e-05 | 2 | 260 | 2 | cv:C1836694 | |
| Disease | endoplasmic reticulum aminopeptidase 2 measurement | 7.73e-05 | 2 | 260 | 2 | EFO_0801566 | |
| Disease | Dysarthria, Mixed | 7.73e-05 | 2 | 260 | 2 | C0454598 | |
| Disease | Dysarthria, Spastic | 7.73e-05 | 2 | 260 | 2 | C0454596 | |
| Disease | Dysarthria, Flaccid | 7.73e-05 | 2 | 260 | 2 | C0454597 | |
| Disease | sinoatrial node disease (implicated_via_orthology) | 7.73e-05 | 2 | 260 | 2 | DOID:0050824 (implicated_via_orthology) | |
| Disease | Dysarthria, Guttural | 7.73e-05 | 2 | 260 | 2 | C1563666 | |
| Disease | Dysarthria, Scanning | 7.73e-05 | 2 | 260 | 2 | C0240952 | |
| Disease | Dysarthria | 7.73e-05 | 2 | 260 | 2 | C0013362 | |
| Disease | intestinal atresia (implicated_via_orthology) | 7.75e-05 | 10 | 260 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 7.75e-05 | 10 | 260 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | PDS5B RELN TEX10 ADCY9 UBTF DLG1 NMT1 NPC1 ADAMTSL3 RUFY1 RIT2 TET1 | 1.04e-04 | 364 | 260 | 12 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 |
| Disease | Autistic Disorder | 1.17e-04 | 261 | 260 | 10 | C0004352 | |
| Disease | diabetes mellitus (is_implicated_in) | 1.18e-04 | 29 | 260 | 4 | DOID:9351 (is_implicated_in) | |
| Disease | platelet component distribution width | PDS5B CAPN14 ITGA2 INPP4B PDS5A GP1BA NPAS2 NPC1 RASA3 WEE1 SYNE1 ABCC5 DNM1L EGF CD9 BTBD7 CATSPERB MYBPC1 | 1.43e-04 | 755 | 260 | 18 | EFO_0007984 |
| Disease | bitter alcoholic beverage consumption measurement | 1.84e-04 | 133 | 260 | 7 | EFO_0010092 | |
| Disease | Liver Cirrhosis, Experimental | ASPN INPP5D INPPL1 CYP26A1 ACTA2 PSME2 BGN GHR FAT1 NPAS2 CNDP1 ENC1 ID2 ABCC5 SMC2 SGK2 EGF PC | 1.94e-04 | 774 | 260 | 18 | C0023893 |
| Disease | cytokine measurement | CATSPERE PDE10A MAGEF1 ITPR1 SYDE2 KCTD15 ECEL1 CYP26B1 DPP10 ANK2 STK31 BABAM2 IFNAR2 | 2.51e-04 | 461 | 260 | 13 | EFO_0004873 |
| Disease | body fat percentage | PDS5B RELN TEX10 ADCY9 UBTF DLG1 NMT1 NPC1 IQCH ADAMTSL3 RUFY1 RIT2 TET1 | 4.32e-04 | 488 | 260 | 13 | EFO_0007800 |
| Disease | Liver diseases | 4.42e-04 | 72 | 260 | 5 | C0023895 | |
| Disease | Liver Dysfunction | 4.42e-04 | 72 | 260 | 5 | C0086565 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 4.59e-04 | 4 | 260 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | 2-methylmalonylcarnitine (C4-DC) measurement | 4.59e-04 | 4 | 260 | 2 | EFO_0800250 | |
| Disease | fasting blood glucose measurement, response to metformin | 4.59e-04 | 4 | 260 | 2 | EFO_0004465, GO_1901558 | |
| Disease | Alcoholic Intoxication, Chronic | 6.63e-04 | 268 | 260 | 9 | C0001973 | |
| Disease | Infiltrating duct carcinoma of female breast | 8.00e-04 | 21 | 260 | 3 | C3165106 | |
| Disease | Colorectal Neoplasms | 8.37e-04 | 277 | 260 | 9 | C0009404 | |
| Disease | Adverse reaction to drug | 8.95e-04 | 84 | 260 | 5 | C0041755 | |
| Disease | Drug toxicity | 8.95e-04 | 84 | 260 | 5 | C0013221 | |
| Disease | hip circumference | PDXDC1 TRPM7 AMZ1 ADCY9 RMC1 NPC1 DPP10 ADAMTSL3 TNNI3K CDH13 | 8.96e-04 | 338 | 260 | 10 | EFO_0005093 |
| Disease | cortical thickness | PDS5B RELN STK17B ADGRV1 WARS2 VSTM4 NEO1 UBTF NFKB1 NAV2 ADAMTSL3 ADAM12 RUFY1 KIF20B RIT2 KLHL38 ARL4C CADPS VCAN MAPK3 CALCRL | 9.31e-04 | 1113 | 260 | 21 | EFO_0004840 |
| Disease | diet measurement | PDXDC1 DNAH14 INPP4B ITPR1 DSTYK RMC1 CNGB1 DPY19L2P1 MYO1H APOB TEX15 SMC2 RIT2 TPK1 ARL4C FRK PTPA CADPS METTL15 CDH13 | 1.08e-03 | 1049 | 260 | 20 | EFO_0008111 |
| Disease | C-reactive protein measurement | NAT2 CYP3A7 RPS6KA1 CYP26A1 PDE10A ADCY9 ITPR1 NEO1 DSTYK NFKB1 AK4 PLD2 RMC1 ATG16L2 NPC1 FAM220A MRPL33 APOB CACHD1 BABAM2 RIT2 FRK | 1.09e-03 | 1206 | 260 | 22 | EFO_0004458 |
| Disease | FNAITP | 1.13e-03 | 6 | 260 | 2 | C3854603 | |
| Disease | spina bifida (is_implicated_in) | 1.13e-03 | 6 | 260 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 1.13e-03 | 6 | 260 | 2 | C3853779 | |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 AMZ1 WARS2 NEO1 DSTYK NAV2 MYLK2 PBRM1 DTWD2 CADPS VCAN CATSPERB MAPK3 | 1.29e-03 | 550 | 260 | 13 | EFO_0004346, EFO_0004464 |
| Disease | comparative body size at age 10, self-reported | RELN NEK10 ADCY9 STXBP1 RMC1 NPC1 ADAMTSL3 TNNI3K CADPS BTBD7 METTL15 | 1.35e-03 | 420 | 260 | 11 | EFO_0009819 |
| Disease | Malignant neoplasm of breast | NAT2 EREG CATSPERE ESRRA RPS6KA3 ACTA2 INPP4B BGN MAGED2 PLD2 ANK2 NRCAM SYNE1 UBR4 MTMR8 ADAM12 RUFY1 PBRM1 EGF MTR | 1.44e-03 | 1074 | 260 | 20 | C0006142 |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 1.58e-03 | 7 | 260 | 2 | EFO_0008119 | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.58e-03 | 7 | 260 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | azoospermia (implicated_via_orthology) | 1.69e-03 | 27 | 260 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | adverse effect, response to xenobiotic stimulus | 1.83e-03 | 59 | 260 | 4 | EFO_0009658, GO_0009410 | |
| Disease | insulin resistance | 1.83e-03 | 59 | 260 | 4 | EFO_0002614 | |
| Disease | osteoarthritis (is_implicated_in) | 1.88e-03 | 28 | 260 | 3 | DOID:8398 (is_implicated_in) | |
| Disease | Liver carcinoma | NAT2 RPS6KA3 INPP4B ADD1 GHR ASPM PYGL CNDP1 IDH1 CRHBP EGF CDH13 | 1.94e-03 | 507 | 260 | 12 | C2239176 |
| Disease | severe pre-eclampsia (is_marker_for) | 2.09e-03 | 8 | 260 | 2 | DOID:13129 (is_marker_for) | |
| Disease | Familial hypercholesterolemia | 2.09e-03 | 8 | 260 | 2 | cv:C0020445 | |
| Disease | Leigh syndrome | 2.09e-03 | 8 | 260 | 2 | cv:C0023264 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.11e-03 | 257 | 260 | 8 | DOID:10652 (is_marker_for) | |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN INPP5D CCDC178 SLFN5 WARS2 GLI2 FER COL6A3 CADPS SLC15A5 CDH13 | 2.20e-03 | 447 | 260 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | chronotype measurement | RELN PDE10A NMT1 NPAS2 NPC1 DOCK1 ANK2 DNAJC16 STK31 CRHBP ARHGAP1 LRPPRC PDE8B TET1 SLC15A5 PC METTL15 | 2.27e-03 | 882 | 260 | 17 | EFO_0008328 |
| Disease | sleep duration, triglyceride measurement | 2.31e-03 | 104 | 260 | 5 | EFO_0004530, EFO_0005271 | |
| Disease | Distal arthrogryposis | 2.67e-03 | 9 | 260 | 2 | cv:C0265213 | |
| Disease | Adult Hepatocellular Carcinoma | 2.67e-03 | 9 | 260 | 2 | C0279607 | |
| Disease | response to simvastatin, PCSK9 protein measurement | 2.67e-03 | 9 | 260 | 2 | EFO_0006899, GO_1903491 | |
| Disease | cancer (implicated_via_orthology) | 2.72e-03 | 268 | 260 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | venous thromboembolism | RELN F8 NUP205 CNOT6 NAV2 AK4 ANK2 WDR59 RIT2 TMLHE CATSPERB | 2.73e-03 | 460 | 260 | 11 | EFO_0004286 |
| Disease | waist-hip ratio | TEX10 WARS2 NUP205 DSTYK DLG1 AK4 RMC1 NPAS2 NPC1 EFL1 TBX4 IQCH ADAMTSL3 MYLK2 RIT2 PTPDC1 PBRM1 CADPS PDE8B CALCRL CDH13 | 2.98e-03 | 1226 | 260 | 21 | EFO_0004343 |
| Disease | colorectal adenoma | 3.03e-03 | 33 | 260 | 3 | EFO_0005406 | |
| Disease | Glioblastoma Multiforme | 3.07e-03 | 111 | 260 | 5 | C1621958 | |
| Disease | neuroimaging measurement | PDXDC1 RELN DPY19L3 STK17B AMZ1 WARS2 NEO1 DSTYK RAB3GAP2 NAV2 TLN2 RUFY1 KIF20B RIT2 CADPS VCAN CALCRL PC DCLK1 | 3.14e-03 | 1069 | 260 | 19 | EFO_0004346 |
| Disease | seasonal gut microbiome measurement | 3.19e-03 | 112 | 260 | 5 | EFO_0007753 | |
| Disease | vital capacity | AMZ1 RPS6KA1 MAGEF1 WARS2 TIAM2 ITPR1 GHR FER DLG1 RMC1 COL6A3 TBX4 CYP26B1 IQCH SYNE1 PCDHA3 APOB ADAMTSL3 STK31 PTPDC1 PC | 3.28e-03 | 1236 | 260 | 21 | EFO_0004312 |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 3.32e-03 | 10 | 260 | 2 | EFO_0022090 | |
| Disease | familial hypercholesterolemia (is_implicated_in) | 3.32e-03 | 10 | 260 | 2 | DOID:13810 (is_implicated_in) | |
| Disease | theophylline measurement | 3.32e-03 | 10 | 260 | 2 | EFO_0021180 | |
| Disease | platelet glycoprotein ib alpha chain measurement | 3.32e-03 | 10 | 260 | 2 | EFO_0020645 | |
| Disease | risk-taking behaviour | RELN ESRRG INPP4B NEO1 DSTYK NPC1 IQCH TNNI3K LRPPRC PBRM1 CADPS PC METTL15 CDH8 CDH13 | 3.41e-03 | 764 | 260 | 15 | EFO_0008579 |
| Disease | Malignant neoplasm of prostate | NAT2 ATR GGT1 ITPR1 GHR DNAJC10 PDS5A TCN2 IDH1 EGF CD9 MAPK3 CDH13 | 3.44e-03 | 616 | 260 | 13 | C0376358 |
| Disease | Prostatic Neoplasms | NAT2 ATR GGT1 ITPR1 GHR DNAJC10 PDS5A TCN2 IDH1 EGF CD9 MAPK3 CDH13 | 3.44e-03 | 616 | 260 | 13 | C0033578 |
| Disease | Prescription Drug Abuse | 3.57e-03 | 115 | 260 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 3.57e-03 | 115 | 260 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.57e-03 | 115 | 260 | 5 | C0029231 | |
| Disease | Drug habituation | 3.57e-03 | 115 | 260 | 5 | C0013170 | |
| Disease | Drug abuse | 3.57e-03 | 115 | 260 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 3.57e-03 | 115 | 260 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.57e-03 | 115 | 260 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.57e-03 | 115 | 260 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.57e-03 | 115 | 260 | 5 | C0038586 | |
| Disease | Bipolar Disorder | 3.60e-03 | 477 | 260 | 11 | C0005586 | |
| Disease | Substance abuse problem | 3.71e-03 | 116 | 260 | 5 | C0740858 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 3.99e-03 | 118 | 260 | 5 | EFO_0010119 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 4.04e-03 | 11 | 260 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Leukoencephalopathy | 4.04e-03 | 11 | 260 | 2 | C0270612 | |
| Disease | juvenile idiopathic arthritis | 4.18e-03 | 74 | 260 | 4 | EFO_0002609 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 4.19e-03 | 171 | 260 | 6 | DOID:9352 (is_implicated_in) | |
| Disease | hypertension (is_implicated_in) | 4.43e-03 | 121 | 260 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | urinary bladder cancer (is_implicated_in) | 4.60e-03 | 76 | 260 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | smoking behavior, body mass index | 4.75e-03 | 123 | 260 | 5 | EFO_0004318, EFO_0004340 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 4.75e-03 | 123 | 260 | 5 | EFO_0007789, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYHPNVDKLERISLD | 76 | Q5JXB2 | |
| LYAKVELIPVHLESE | 276 | Q4AC99 | |
| KDSLTDLYVQHAIPL | 46 | Q9BVC5 | |
| KALVSLPANIHVLFY | 351 | P59826 | |
| QEILQYLLPIVHSTK | 826 | Q8NEM8 | |
| LVPAYNHLLEKAELL | 36 | Q8NAA4 | |
| EKQLALHELIPATTY | 141 | P56559 | |
| LARKHIYLQPIDLSE | 91 | Q400G9 | |
| EISKLYPHVVDLKVT | 171 | Q9H7T0 | |
| VIVESYGPKILQESH | 621 | Q5SY80 | |
| TKFHPDINVYIIEVR | 1316 | P13611 | |
| LVAIELAYINTKHPD | 486 | O00429 | |
| VAHLYSNLTKPILDV | 221 | Q9UBJ2 | |
| ILTLKYPIEHGIITN | 66 | P68133 | |
| HIPGDNSIYVTKIIE | 341 | Q12959 | |
| LIVELKFTPQEAYSH | 151 | Q7Z2Z2 | |
| LHVYPEVLLSEETKR | 196 | Q7Z4H9 | |
| VENALHLHLIVKPVY | 456 | A6NE02 | |
| LQSIYLVPEEDHILI | 266 | Q8WXG9 | |
| ILTLKYPIEHGIITN | 66 | P62736 | |
| DIIHYENIPKFELVR | 536 | Q5VU97 | |
| LIEIANHVDKFYRPL | 241 | O43184 | |
| SLDHYLKALQPIVSE | 46 | P43155 | |
| VEPTEYLVVHLKGSL | 156 | P15144 | |
| QYFIEHKLLTPDVQD | 81 | Q9UIA0 | |
| TVDLKPETAYNLIHT | 456 | Q6ZPD9 | |
| ISKECNLVYLIPHAV | 381 | P21728 | |
| VVKPLDYEISAFHTL | 426 | P55290 | |
| YIIQHPAEENKVLRT | 96 | Q8NBA8 | |
| HLLKSARYLQQELPV | 86 | O14874 | |
| YLKVHSNLVIPDVEL | 486 | Q8TAM1 | |
| LVVIPLKLHQIEYVV | 1616 | Q96MT7 | |
| KILHIDDYELPLQLS | 536 | Q8N608 | |
| TIAHEIYQKILSPDS | 356 | Q8IZT6 | |
| PTLLELHLDYNKIST | 241 | Q9BXN1 | |
| YLIVPCILEAHQKSE | 471 | A8MX76 | |
| IVKLAQEPCYHEIIT | 886 | Q9NTI5 | |
| PKELYIIEHGSNVTL | 26 | Q9BQ51 | |
| EKIFAQYLVPHNLET | 466 | Q29RF7 | |
| KQEAAVPLVRLFLHY | 331 | Q14644 | |
| YLHVTLKPAIEEICQ | 391 | Q14644 | |
| LLEHVEKFLRNYAIP | 301 | Q86VS3 | |
| HQLPLLTEKQYIATI | 296 | Q92621 | |
| YLLLQPIRKEVIHLE | 331 | Q7Z4N8 | |
| NFLPEQEHSEVYKIL | 131 | Q99743 | |
| VTLHAVLPYLLDKAL | 96 | O60683 | |
| LLQHKAPVDDVTLDY | 351 | Q01484 | |
| VELALEQKHIHYPLV | 1141 | Q9H2M9 | |
| ETVLKIVAYGLVLHP | 141 | O60840 | |
| KHLQDLFAPLVVRYV | 971 | Q9ULU8 | |
| KDSNALLVYHIVEPS | 1801 | Q14517 | |
| NTVKRFHLYPEVIIA | 181 | Q6NXN4 | |
| PESLIYKDALVLHKV | 741 | Q86U86 | |
| NREDTPKHYLLITAI | 201 | Q9Y5H8 | |
| DVARILPQIKSLHYF | 351 | Q5VXI9 | |
| EPLANTKEIIGYVLH | 446 | Q8IVU1 | |
| LDLKEVEPNKHIYVL | 166 | Q96LZ2 | |
| KNDHLYILLSTLEPT | 341 | Q9UNF1 | |
| HTYILINKLKPLEEE | 141 | Q9HAY2 | |
| ISAIPANIHIYDTEK | 226 | P30419 | |
| HVLVYENPALQEKAL | 181 | Q96IV0 | |
| HSYLERLLNVEVPQK | 356 | Q9NQS7 | |
| IYVLHENGTLEIPVA | 501 | Q92823 | |
| HAVVLELLQIPYEKA | 1221 | Q14643 | |
| HEVYISLLKLSQPAL | 91 | Q96EF0 | |
| QYIEKSLLVPDHVIT | 56 | P27144 | |
| KVEVQLPELYHKIGV | 276 | Q14722 | |
| VHRDLKPSNILYVDE | 536 | P51812 | |
| VDILHNIDPIYTKAK | 416 | Q5FYB0 | |
| HEALESYLPKIQLVI | 151 | Q9NR63 | |
| LQIKEGQLLHVYPVL | 731 | O15327 | |
| KIEVPLYSLLEQTHL | 316 | Q92598 | |
| NIVHRDIKPENLLVY | 506 | O15075 | |
| EYHLNPETITILFVK | 621 | O95786 | |
| QELPLAVQKEHEAYL | 211 | Q5BJE1 | |
| TDLLLKLLNHYQAVP | 76 | Q9UBQ6 | |
| EKVAILAQLYHEKPL | 91 | Q96F63 | |
| LAQLYHEKPLVFLER | 96 | Q96F63 | |
| LVAPLIIYHVIDANS | 251 | Q14654 | |
| IVSELTIIKEQLYHP | 571 | Q6ZWH5 | |
| LVKIIYKNTPENLHE | 241 | Q53H82 | |
| LILVIIKYENSLHIP | 46 | Q9H2C5 | |
| YILHLDLKPENILCV | 631 | Q32MK0 | |
| NLIQLYAAIETPHEI | 341 | Q9H1R3 | |
| DEKVKAYLSLHPQVL | 16 | Q9Y233 | |
| HKELLEKLVLYPSAQ | 411 | Q6L8Q7 | |
| LPDLKLLQVVYLHSN | 296 | P21810 | |
| VTLYKHDDPALTLVA | 311 | Q6P996 | |
| IFELEAITHKRPLVY | 561 | O95263 | |
| PNVTLLEELLSKYQH | 26 | Q9H0B8 | |
| KTPDLEILHYVVDGI | 71 | Q5VWM3 | |
| KQAEIAHLYIASLPD | 691 | Q96Q89 | |
| FLKIYLEVDNVPRHL | 56 | P23743 | |
| IYAPTLLVFKEHINR | 321 | Q9Y2G8 | |
| TYHKVDLRLQTLEIP | 161 | Q9NP85 | |
| DLHYIVRKLAAPVIS | 801 | O60337 | |
| ALIHQLKINPYVLSD | 711 | Q9UIQ6 | |
| IRNLLESYHVPELIK | 626 | P42704 | |
| KSYEILLHEVPIEGQ | 31 | O00522 | |
| VLPDDVVQYIKAHAS | 1061 | P10070 | |
| VELLPKVHIYQKDLF | 1511 | P00451 | |
| NKRITVEEALAHPYL | 316 | P27361 | |
| ALAEHLSELYPKQIR | 126 | P0C7V9 | |
| PSSELLEKYHIIDQF | 96 | A2A3K4 | |
| YVHRDIKPDNVLLDV | 196 | Q9Y5S2 | |
| ALAEHLSELYPKQIR | 126 | A6NJ78 | |
| EIVAIKILKNHPSYA | 221 | Q9H422 | |
| VNLKIPLLYDAEIHL | 926 | P17301 | |
| EKVIPLEYLEAIHHL | 201 | O00142 | |
| VNDFLPVITYALHKD | 241 | Q6XUX3 | |
| QSIYLQVLTDKHAPE | 726 | O95672 | |
| QIVIIEHKSIICPGY | 396 | P15170 | |
| VVYPLSKNHLVVLAI | 186 | P46089 | |
| KLLETKPEYHSLLQE | 396 | Q969R8 | |
| AIEIYLKLHDNPLTD | 561 | Q9BXJ9 | |
| VSTIIHILYLPEDAK | 306 | P78509 | |
| YLEHSDEQAVIKSPL | 211 | P48551 | |
| ARLQKILHSYVPEEI | 211 | Q96CB9 | |
| EQLIIRAPLTDKHIY | 406 | O15118 | |
| AVIAKASAIHNPIIY | 336 | Q9UHM6 | |
| ERINHYIKTLSLEAP | 1161 | O15440 | |
| HPKLIQLYAVCTLED | 286 | P42685 | |
| IIHCDLKPENIVLYQ | 226 | Q9NR20 | |
| ELHAYILRVDPVNFK | 86 | P02008 | |
| VHANPLLIDVVTYLV | 401 | P04114 | |
| QPKETAAIFHYLIIE | 1226 | Q13535 | |
| DEPQRETLKAIHYAL | 136 | P21926 | |
| KTAPAVVYIEILDRH | 156 | O43464 | |
| IKEKLIFPYVELDLH | 26 | O75874 | |
| HLPVSAEIKELFQYI | 71 | Q9NQC8 | |
| NISDHYPVEVELKLS | 261 | P49184 | |
| YPVEVELKLSQAHSV | 266 | P49184 | |
| HILEVLYRKDVGPTQ | 886 | Q14185 | |
| LVGDIIQIRKDYPHL | 386 | Q92608 | |
| LQVAALKYIPSVLHD | 791 | Q92608 | |
| LIDYVPQVCHLLTNK | 246 | Q9NXR7 | |
| IYQFHIEKTGPLLIE | 716 | Q9Y6W3 | |
| YPVVIKISDLTLGHV | 211 | P24387 | |
| EVNTILAIHDSYKPE | 321 | P10912 | |
| HILLSALKYPANVAV | 151 | P01133 | |
| ILKQYDHPNIVKLIG | 611 | P16591 | |
| DLSQIPYINLVKHLT | 51 | Q5T2R2 | |
| KIVSHLLVAEPEKIY | 236 | P62508 | |
| LPYIVGVAQRHIVLK | 416 | P12111 | |
| RNKVIIEYPTLHVVL | 431 | Q9NWK9 | |
| LLRNIIPYHVAEQLK | 1031 | O60503 | |
| PLHSYELLKENETIA | 456 | Q6IQ26 | |
| DESIIPKKYATVILH | 316 | Q9P203 | |
| ASIKDYIHIIQSLPD | 3071 | Q0VDD8 | |
| PKDTTILHLSENLLY | 46 | P07359 | |
| HQKIYLFTLEPRTIE | 186 | P11245 | |
| ELKVLSYPAHEQIAL | 136 | Q6P179 | |
| VPEKVKDAYLVHLIQ | 226 | Q9Y6V7 | |
| LGLYPHVLQKVREEL | 316 | O43174 | |
| PFYLIIDHLISKAEE | 951 | Q9H583 | |
| NSIHPEVLELLLDYA | 91 | O14682 | |
| HQPLSKEYVALTVIL | 111 | O14944 | |
| YTLKVEAANVHIDPR | 351 | P55286 | |
| VVHEVQRYIDLLPTS | 351 | P11712 | |
| FIIYELATHPDVQQK | 316 | P24462 | |
| AKEIYLEVIHNLPDF | 336 | Q8IXB1 | |
| IPKTEQHRLFYVALL | 146 | A6NIM6 | |
| VDDLEVYLKHLLPKI | 3471 | Q9NZJ4 | |
| ALVSHLLVVEPEKLY | 196 | P11474 | |
| HSLISPYIQQLEKLA | 611 | O94829 | |
| IHDIENVLLKPENLY | 446 | Q16602 | |
| IPSDIAKLHNLVYLD | 66 | Q9ULM6 | |
| EIQKLHIRTVPLYES | 706 | Q16531 | |
| HQPKILYLEDLDLSS | 731 | Q6P995 | |
| LETLNLYHNCIKTIP | 136 | Q5VUJ6 | |
| KPVQEAHSTLVETLY | 551 | O14829 | |
| FKLEPLQAYHRVISL | 91 | Q9H488 | |
| AYNSLTEAVLPKLHL | 86 | Q9BPW8 | |
| LEHKIIIRVQTTPDY | 66 | Q9H1A7 | |
| HQLAVKLEPRGLIYV | 776 | Q5VT97 | |
| KYLIATSEQPIAALH | 266 | P49591 | |
| PVLQAADILLYKSTH | 161 | Q9UGM6 | |
| YQHILLSLQKILADP | 286 | Q9Y6J9 | |
| YLVTLLVVVPKLNHN | 181 | P21283 | |
| VELPLTHFELYKQIG | 181 | P43686 | |
| HSLNIIYRDLKPENI | 151 | Q9HBY8 | |
| LAHIESELAKPIVYD | 7901 | Q8NF91 | |
| APVLYLHDQLSELLK | 1046 | Q9HCM1 | |
| RHTYEIPLVLVGNKI | 121 | Q99578 | |
| KTPDLEILHYVVDGI | 71 | Q5SWL8 | |
| VLIDNKHLLSEFYEP | 226 | Q96T51 | |
| DPIISTHLAKLYDNL | 316 | O00231 | |
| YILDLQIALDSHPTI | 71 | Q02363 | |
| TELLIVVKYDPHTLT | 391 | Q9BVG9 | |
| NLPVYDDIHKELLQL | 616 | Q99707 | |
| IENLDPSSHYVITLK | 796 | Q92859 | |
| LFKEYIIHVDPVSQL | 2061 | Q8IVL1 | |
| DQYNELHLPAVILKT | 306 | Q07960 | |
| HLDLKPQNILLSSIY | 156 | O94768 | |
| LPEEHLKAIQDYLST | 176 | Q92835 | |
| ISDPEYLLDQHILIS | 791 | Q92835 | |
| LKPILADIEYLQDQH | 806 | O15357 | |
| KLPVHVEDALTYLDQ | 36 | O75182 | |
| LYHIISSNLEKIVNP | 216 | Q9UL46 | |
| SVIRIYLDHLNNPEK | 926 | Q8NEZ3 | |
| ELHVQKIYVISLAEP | 136 | P14868 | |
| TYDPLLDLIAVINHD | 356 | Q14181 | |
| LEAVYLITPSEKSVH | 71 | P61764 | |
| QLLPVLNHKTYIDLI | 291 | P20062 | |
| QDEQLHVLPLYKLSD | 1701 | Q8NFU7 | |
| PSLVDYLLNLKEHLE | 191 | A8MXE2 | |
| ILTLKYPIEHGIITN | 66 | P68032 | |
| ASKAIIEKEYQPHVI | 541 | P35611 | |
| YVAGIELLHQKLELP | 191 | Q9NY35 | |
| PLTEEEINTYKAIHL | 301 | Q96KN2 | |
| DLNEILVHYPESQKL | 1061 | Q14028 | |
| KKTLQEILVHYPDSE | 621 | Q9NQW8 | |
| LSVLVLLPVEVATHY | 226 | O95436 | |
| LLPVEVATHYLEIIT | 231 | O95436 | |
| LEHKIIIRVQTTPDY | 66 | Q9GZM3 | |
| VEIISLLEEQLPHYK | 41 | Q9UPV9 | |
| LIEYLNKSPSVDHLL | 616 | Q9BXU1 | |
| HTIILKNLCVELYPA | 401 | Q5VXH4 | |
| IEHLNKTYNTDVPLV | 146 | Q16851 | |
| EVLQENYTHLPKADI | 486 | P30291 | |
| KHATIYPTEQELLAV | 596 | Q9UPR6 | |
| KRPSITQVDELLHIY | 781 | Q8IVF5 | |
| VDPLFLLLHYLIKAD | 91 | Q5TBB1 | |
| LTLLHYDPVVKQRVL | 41 | O75394 | |
| LPETYSKINHVLIEA | 536 | Q9H5L6 | |
| LPVIATVFDKLNHEY | 406 | Q96DM3 | |
| QYTVIVGFEHLKLPI | 281 | Q9P2C4 | |
| PIVLDSLKQHYFIDR | 91 | Q96SI1 | |
| THLAAAVPEVAVYLK | 161 | Q15257 | |
| HTIILKNLCVELYPA | 401 | Q5TYX0 | |
| IYKTIAHFLPNDLEI | 376 | Q8IZM8 | |
| LKDLLSQYPFIIDAH | 81 | Q9NXF1 | |
| VHLQADPTKLELLYK | 341 | O95391 | |
| PKELTLQKGDIVYIH | 396 | O60504 | |
| YLLVKGTIPVEIHTA | 3921 | Q86WI1 | |
| NYLLEEILDKVHSIP | 231 | Q9UIL8 | |
| AHVDLIEKLLNYAPL | 51 | P62875 | |
| VYAIPLALSTEAILH | 216 | Q9Y5Z9 | |
| DNVHVALSLVEYKPE | 601 | O95347 | |
| NDATEILYSHVVKPV | 26 | Q6X4U4 | |
| LEHVPLLLYILAAKT | 6 | P58511 | |
| LPVHKSLGELYILNV | 656 | Q6PJI9 | |
| ILEGVPSHLNVDYIK | 331 | O14863 | |
| KNVVIESDLYTHQPL | 41 | Q8TAG6 | |
| HKVTQLASYFEPLIL | 1731 | Q9Y4G6 | |
| NLTYAELELIKPHRA | 286 | Q8IW00 | |
| TKYILLIDIVPADDH | 111 | P57082 | |
| LADIVTELYQRKPHA | 1631 | Q9Y4F4 | |
| NETKISPIDNYIVLH | 266 | Q9BXT5 | |
| YNLAIVHIELKEPNE | 601 | Q6ZXV5 | |
| TELILDAQEHVKNPY | 86 | P17480 | |
| EPTYQLNIHDIKLLF | 4951 | Q5T4S7 | |
| VKYLLQSDLEVQPHV | 251 | Q59H18 | |
| DLVEKLLPRHLEIIY | 391 | P06737 | |
| LLPRHLEIIYEINQK | 396 | P06737 | |
| CSILIQIISHYKEEP | 401 | Q9H3S5 | |
| IYELQSLKVHPLVFA | 46 | O14939 | |
| LLSKVPLKHEYIEDV | 291 | Q9NVH6 | |
| AVISPHYDSLLVKVI | 416 | P11498 | |
| KVEVYPVELLLVRHN | 191 | P51784 | |
| LQYLEKLNLPESTHV | 181 | Q08AF3 | |
| RPEIKYVLNFLEVHD | 271 | Q08AF3 | |
| ILYTRKPVAEILHES | 536 | O95932 | |
| HKFLTIPRLEELYNT | 466 | Q96QT4 | |
| EAKLVIFPDHYEIAL | 136 | Q92995 | |
| IQEESLIYLLQPGKH | 156 | Q9H3S4 | |
| VQLLDQIPSYDTHKI | 1531 | P49815 | |
| PQNSVIIEYKRLHAE | 201 | Q8NB42 | |
| IYQLVAELAKAQPTH | 1121 | P82987 | |
| IEHPLNISLGDVVLY | 261 | P19440 | |
| VLHPAVAVKDQRLYL | 421 | Q2WGJ6 | |
| HKVDLPFQEYVEQLL | 106 | Q96S16 | |
| VVHRDLKPSNILYVD | 531 | Q15418 | |
| LQLISHEKIQYGVPV | 881 | Q8N1T3 | |
| DAYNVTLPAKVHVID | 506 | Q00872 | |
| LYQTPLHLAVITKQE | 581 | P19838 |